2025/04/30 更新

写真a

タカハシ ヒデヒサ
髙橋 秀尚
Hidehisa Takahashi
所属
医学研究科 医科学専攻 分子生物学 主任教授
医学部 医学科
職名
主任教授
プロフィール
私達の体は数十兆個という非常に多くの細胞から形成されています。そんな1つ1つの細胞がDNAからなる遺伝子を持っています。細胞内において、遺伝子の情報はまず初めにRNAに写し取られ(転写)、さらにRNAの情報はタンパク質に変換されることによって、初めて遺伝子は機能を発揮し、細胞は生命活動を行うことができます。このRNAが合成される転写の“速さ”の調節が破綻すると、生命機能の破綻を引き起こし、がんや白血病などの腫瘍性疾患や遺伝性疾患などを引き起こす要因となることがわかってきました。私は、転写の“速さ”(転写伸長)の調節機構に着目し研究を行っております。
外部リンク

学位

  • 博士(医学) ( 九州大学 )

研究キーワード

  • 転写

  • RNAポリメラーゼⅡ

  • 遺伝子発現制御

  • 転写伸長

研究分野

  • ライフサイエンス / 医化学

学歴

  • 九州大学   医学部

    - 2001年

      詳細を見る

    国名: 日本国

    researchmap

  • 九州大学

    - 2001年

      詳細を見る

経歴

  • 横浜市立大学   分子生物学分野   教授

    2017年10月 - 現在

      詳細を見る

  • 北海道大学   生化学講座 医化学分野   講師

    2015年4月 - 2017年9月

      詳細を見る

  • 北海道大学   生化学講座 医化学分野   助教

    2011年10月 - 2015年3月

      詳細を見る

  • ストワーズ医学研究所   コナウェイ研究室   博士研究員

    2006年4月 - 2011年9月

      詳細を見る

  • 九州大学   九州大学大学院医学系学府   大学院生

    2001年4月 - 2005年3月

      詳細を見る

  • 九州大学

    2001年3月

      詳細を見る

▼全件表示

論文

  • Biallelic TEDC1 variants cause a new syndrome with severe growth impairment and endocrine complications. 国際誌

    Noriko Miyake, Kentaro Shiga, Yuya Hasegawa, Chisato Iwabuchi, Kohei Shiroshita, Hiroshi Kobayashi, Keiyo Takubo, Fabien Velilla, Akiteru Maeno, Toshihiro Kawasaki, Yukiko Imai, Noriyoshi Sakai, Tomonori Hirose, Atsushi Fujita, Hidehisa Takahashi, Nobuhiko Okamoto, Mikako Enokizono, Shiho Iwasaki, Shuichi Ito, Naomichi Matsumoto

    European journal of human genetics : EJHG   2025年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We encountered two affected male patients born to non-consanguineous parents, who presented with prenatal-onset severe growth impairment, primary microcephaly, developmental delay, adrenal insufficiency, congenital glaucoma, delayed bone aging, craniosynostosis, congenital tracheal stenosis, and primary hypogonadism. By exome sequencing, we identified compound heterozygous TEDC1 variants (NM_001134877.1 c.[104-5C>G];[787delG] p.[?];[(Ala263LeufsTer29)] in both affected siblings. We confirmed that the splice site variant, c.104-5C>G, leads to no TEDC1 protein production via nonsense-mediated mRNA decay. The frameshift variant located in the last coding exon, c.787delG, produces a C-terminally truncated protein, which impairs the binding with TEDC2. Thus, both variants are thought to be loss-of-function. TEDC1 and TEDC2 are both required for centriole stability and cell proliferation. Our in vitro experiments using patient-derived cells revealed cell cycle abnormality. Our in vivo study using tedc1-/- zebrafish generated by CRISPR/Cas9 successfully recapitulated the growth impairment and cranial bone dysplasia as seen in our patients. The tedc1-/- mutant zebrafish were sterile and did not have developed gonads. Furthermore, we showed that biallelic TEDC1 deletion causes cilia abnormalities through defective acetylated tubulins.

    DOI: 10.1038/s41431-025-01802-3

    PubMed

    researchmap

  • A Novel AGR2 Variant Causing Aberrant Monomer-Dimer Equilibrium Leading to Severe Respiratory and Digestive Symptoms. 国際誌

    Sanami Takada, Silvanna Gallo, Sebastian Silva, Hiroki Tanaka, Oscar Pincheira, Juan Zúñiga, Marcela Villarroel, Ximena Hidalgo, Joel Melo-Tanner, Hidefumi Suzuki, Shinichi Machida, Hidehisa Takahashi, Noriko Miyake

    Journal of clinical immunology   45 ( 1 )   55 - 55   2024年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Anterior gradient 2 (AGR2) is a protein disulfide isomerase that is important for protein processing in the endoplasmic reticulum and is essential for mucin production in the digestive and respiratory tracts. Bi-allelic AGR2 variants were recently found to cause recurrent respiratory infections and failure to thrive with or without diarrhea (RIFTD; MIM # 620233), although the mechanisms behind this condition remain unclear. To date, at least 15 patients with homozygous AGR2 variants have been reported. Here, we report two affected siblings in a consanguineous family who had recurrent respiratory infections and digestive symptoms, one of whom needed lung transplantation. To identify the genetic cause of their symptoms, we performed exome sequencing and identified a novel homozygous missense variant in AGR2 (NM_006408.4, c.250A>C, p.(Ser84Arg)) in both affected siblings. Both parents had the identical variant in a heterozygous state. This variant is quite rare in the general population and is clinically compatible with RIFTD, substituting a highly conserved CXXS motif with CXXR. We performed structural modeling and functional studies to investigate the effect of this variant. Through transient overexpression, Ser84Arg AGR2 decreased protein stability, and promoted aberrant dimerization under non-reducing conditions. AGR2 functions in a monomer-dimer equilibrium. Size-exclusion chromatography showed that the Ser84Arg mutant had a larger molecular size than the wild-type protein under non-reducing, but not reducing conditions, indicating that Ser84Arg enhanced intermolecular disulfide bonds. In conclusion, we identified a novel pathogenic AGR2 variant and indicated its abnormal monomer-dimer equilibrium as a possible mechanism involved in the pathogenesis of RIFTD.

    DOI: 10.1007/s10875-024-01847-x

    PubMed

    researchmap

  • Multi-omics analysis using antibody-based in situ biotinylation technique suggests the mechanism of Cajal body formation. 国際誌

    Keisuke Noguchi, Hidefumi Suzuki, Ryota Abe, Keiko Horiuchi, Rena Onoguchi-Mizutani, Nobuyoshi Akimitsu, Shintaro Ogawa, Tomohiko Akiyama, Yoko Ike, Yoko Ino, Yayoi Kimura, Akihide Ryo, Hiroshi Doi, Fumiaki Tanaka, Yutaka Suzuki, Atsushi Toyoda, Yuki Yamaguchi, Hidehisa Takahashi

    Cell reports   43 ( 9 )   114734 - 114734   2024年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Membrane-less subcellular compartments play important roles in various cellular functions. Although techniques exist to identify components of cellular bodies, a comprehensive method for analyzing both static and dynamic states has not been established. Here, we apply an antibody-based in situ biotinylation proximity-labeling technique to identify components of static and dynamic nuclear bodies. Using this approach, we comprehensively identify DNA, RNA, and protein components of Cajal bodies (CBs) and then clarify their interactome. By inhibiting transcription, we capture dynamic changes in CBs. Our analysis reveals that nascent small nuclear RNAs (snRNAs) transcribed in CBs contribute to CB formation by assembling RNA-binding proteins, including frontotemporal dementia-related proteins, RNA-binding motif proteins, and heterogeneous nuclear ribonucleoproteins.

    DOI: 10.1016/j.celrep.2024.114734

    PubMed

    researchmap

  • Chimera RNA transcribed from integrated HPV18 genome with adjacent host genomic region promotes oncogenic gene expression through condensate formation. 査読 国際誌

    Kazuki Furugori, Hidefumi Suzuki, Ryota Abe, Keiko Horiuchi, Tomohiko Akiyama, Tomonori Hirose, Atsushi Toyoda, Hidehisa Takahashi

    Genes to cells : devoted to molecular & cellular mechanisms   2024年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Most cervical cancers are caused by human papillomavirus (HPV) infection. In HeLa cells, the HPV18 viral genome is integrated at chromosome 8q24.21 and activates transcription of the proto-oncogene c-Myc. However, the mechanism of how the integrated HPV genome and its transcribed RNAs exhibit transcription activation function has not been fully elucidated. In this study, we found that HPV18 transcripts contain an enhancer RNA-like function to activate proximal genes including CCAT1-5L and c-Myc. We showed that the human genome-integrated HPV18 genes are activated by transcription coregulators including BRD4 and Mediator. The transcribed HPV18 RNAs form a liquid-like condensate at chromosome 8q24.21 locus, which in turn accumulates RNA polymerase II. Moreover, we focused on a relatively uncharacterized transcript from the upstream region of CCAT1, named URC. The URC RNA is transcribed as a chimera RNA with HPV18 and is composed of the 3'-untranslated region of the HPV18 transcript. We experimentally showed that the URC contributes to stabilization of HPV18 RNAs by supplying a polyadenylation site for the HPV18 transcript. Our findings suggest that integrated HPV18 at 8q24.21 locus produces HPV18-URC chimera RNA and promotes tumorigenesis through RNA-based condensate formation.

    DOI: 10.1111/gtc.13121

    PubMed

    researchmap

  • Behavioral and histological analyses of the mouse Bassoon p.P3882A mutation corresponding to the human BSN p.P3866A mutation. 国際誌

    Daiki Tanaka, Hiroaki Yaguchi, Kaichi Yoshizaki, Akihiko Kudo, Fumiaki Mori, Taichi Nomura, Jing Pan, Yasuo Miki, Hidehisa Takahashi, Taichi Hara, Koichi Wakabayashi, Ichiro Yabe

    Frontiers in neuroscience   18   1414145 - 1414145   2024年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Tauopathy is known to be a major pathognomonic finding in important neurodegenerative diseases such as progressive supranuclear palsy (PSP) and corticobasal degeneration. However, the mechanism by which tauopathy is triggered remains to be elucidated. We previously identified the point mutation c.11596C > G, p.Pro3866Ala in the Bassoon gene (BSN) in a Japanese family with PSP-like syndrome. We showed that mutated BSN may have been involved in its own insolubilization and tau accumulation. Furthermore, BSN mutations have also been related to various neurological diseases. In order to further investigate the pathophysiology of BSN mutation in detail, it is essential to study it in mouse models. We generated a mouse model with the mouse Bassoon p.P3882A mutation, which corresponds to the human BSN p.P3866A mutation, knock-in (KI) and we performed systematic behavioral and histological analyses. Behavioral analyses revealed impaired working memory in a Y-maze test at 3 months of age and decreased locomotor activity in the home cage at 3 and 12 months of age in KI mice compared to those in wild-type mice. Although no obvious structural abnormalities were observed at 3 months of age, immunohistochemical studies showed elevation of Bsn immunoreactivity in the hippocampus and neuronal loss without tau accumulation in the substantia nigra at 12 months of age in KI mice. Although our mice model did not show progressive cognitive dysfunction and locomotor disorder like PSP-like syndrome, dopaminergic neuronal loss was observed in the substantia nigra in 12-month-old KI mice. It is possible that BSN mutation may result in dopaminergic neuronal loss without locomotor symptoms due to the early disease stage. Thus, further clinical course can induce cognitive dysfunction and locomotor symptoms.

    DOI: 10.3389/fnins.2024.1414145

    PubMed

    researchmap

  • RNA foci in two bi-allelic RFC1 expansion carriers. 国際誌

    Taishi Wada, Hiroshi Doi, Masaki Okubo, Mikiko Tada, Naohisa Ueda, Hidefumi Suzuki, Wakana Tominaga, Haruki Koike, Hiroyasu Komiya, Shun Kubota, Shunta Hashiguchi, Haruko Nakamura, Keita Takahashi, Misako Kunii, Kenichi Tanaka, Yosuke Miyaji, Yuichi Higashiyama, Eriko Koshimizu, Satoko Miyatake, Masahisa Katsuno, Satoshi Fujii, Hidehisa Takahashi, Naomichi Matsumoto, Hideyuki Takeuchi, Fumiaki Tanaka

    Annals of neurology   2023年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) is a late-onset, autosomal recessive neurodegenerative disorder caused by biallelic AAGGG/ACAGG repeat expansion (AAGGG-exp/ACAGG-exp) in RFC1. The recent identification of patients with CANVAS exhibiting compound heterozygosity for AAGGG-exp and truncating variants supports the loss-of-function of RFC1 in CANVAS patients. We investigated the pathological changes in two autopsied patients with CANVAS harboring biallelic ACAGG-exp and AAGGG-exp. RNA fluorescence in situ hybridization of the two patients revealed CCTGT- and CCCTT-containing RNA foci, respectively, in neuronal nuclei of tissues with neuronal loss. Our findings suggest that RNA toxicity may be involved in the pathogenesis of CANVAS. This article is protected by copyright. All rights reserved.

    DOI: 10.1002/ana.26848

    PubMed

    researchmap

  • Sez6l2 autoimmunity in a large cohort study. 国際誌

    Megumi Abe, Hiroaki Yaguchi, Akihiko Kudo, Azusa Nagai, Shinichi Shirai, Ikuko Takahashi-Iwata, Masaaki Matsushima, Naoko Nakamura, Kenji Isahaya, Yoshihisa Yamano, Shinji Ashida, Takashi Kasai, Keiko Tanaka, Masashi Watanabe, Takeshi Kondo, Hidehisa Takahashi, Shigetsugu Hatakeyama, Akira Takekoshi, Akio Kimura, Takayoshi Shimohata, Ichiro Yabe

    Journal of neurology, neurosurgery, and psychiatry   94 ( 8 )   667 - 668   2023年6月

     詳細を見る

  • MED26-containing Mediator may orchestrate multiple transcription processes through organization of nuclear bodies. 国際誌

    Hidefumi Suzuki, Kazuki Furugori, Ryota Abe, Shintaro Ogawa, Sayaka Ito, Tomohiko Akiyama, Keiko Horiuchi, Hidehisa Takahashi

    BioEssays : news and reviews in molecular, cellular and developmental biology   e2200178   2023年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mediator is a coregulatory complex that plays essential roles in multiple processes of transcription regulation. One of the human Mediator subunits, MED26, has a role in recruitment of the super elongation complex (SEC) to polyadenylated genes and little elongation complex (LEC) to non-polyadenylated genes, including small nuclear RNAs (snRNAs) and replication-dependent histone (RDH) genes. MED26-containing Mediator plays a role in 3' Pol II pausing at the proximal region of transcript end sites in RDH genes through recruitment of Cajal bodies (CBs) to histone locus bodies (HLBs). This finding suggests that Mediator is involved in the association of CBs with HLBs to facilitate 3' Pol II pausing and subsequent 3'-end processing by supplying 3'-end processing factors from CBs. Thus, we argue the possibility that Mediator is involved in the organization of nuclear bodies to orchestrate multiple processes of gene transcription.

    DOI: 10.1002/bies.202200178

    PubMed

    researchmap

  • Author Correction: Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization. 国際誌

    Eriko Abe, Akio Yamashita, Keigo Hirota, Takahiro Yamaji, Kengo Azushima, Shingo Urate, Toru Suzuki, Shohei Tanaka, Shinya Taguchi, Shunichiro Tsukamoto, Tatsuki Uehara, Hiromichi Wakui, Kouichi Tamura, Hidehisa Takahashi

    Scientific reports   12 ( 1 )   21322 - 21322   2022年12月

     詳細を見る

  • Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis. 国際誌

    Yusuke Nakai, Kei Miyakawa, Yutaro Yamaoka, Yasuyoshi Hatayama, Mayuko Nishi, Hidefumi Suzuki, Hirokazu Kimura, Hidehisa Takahashi, Yayoi Kimura, Akihide Ryo

    Microorganisms   10 ( 12 )   2022年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Hepatitis B virus (HBV) core antigen (HBc) is a structural protein that forms the viral nucleocapsid and is involved in various steps of the viral replication cycle, but its role in the pathogenesis of HBV infection is still elusive. In this study, we generated a mouse monoclonal antibody (mAb) against HBc and used it in antibody-based in situ biotinylation analysis in order to identify host proteins that interact with HBc. HBc antigen was produced with a wheat germ cell-free protein synthesis system and used to immunize mice. Among the established hybridoma clones, a single clone (mAb #7) was selected and further characterized for its ability in the antibody-based in situ biotinylation analysis to collect host proteins that are in the vicinity of HBc. Using mass spectrometry, we identified 215 HBc-interacting host proteins, three of which bind HBc most significantly under hypoxic conditions. Our results indicate that mAb #7 can be used to systematically identify host proteins that interact with HBc under pathophysiological conditions, and thus may be useful to explore the molecular pathways involved in HBV-induced cytopathogenesis.

    DOI: 10.3390/microorganisms10122381

    PubMed

    researchmap

  • Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization. 国際誌

    Eriko Abe, Akio Yamashita, Keigo Hirota, Takahiro Yamaji, Kengo Azushima, Shingo Urate, Toru Suzuki, Shohei Tanaka, Shinya Taguchi, Shunichiro Tsukamoto, Tatsuki Uehara, Hiromichi Wakui, Kouichi Tamura, Hidehisa Takahashi

    Scientific reports   12 ( 1 )   17376 - 17376   2022年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Kidney fibrosis is a common pathway that leads to chronic kidney disease. Angiotensin II type-1 receptor (AT1R)-associated protein (ATRAP) was originally identified as an AT1R-binding protein. Previously, we reported that systemic knockout of ATRAP exacerbates kidney fibrosis in aged mice. Although these effects of ATRAP appeared to be AT1R-independent actions, the molecular mechanism remains poorly understood. To elucidate the molecular mechanism of ATRAP independent of AT1R, we explored novel ATRAP-interacting proteins. Mass spectrometric analysis of the immunoprecipitants of a Flag-tagged ATRAP complex revealed 376 candidate proteins that potentially interact with ATRAP. Gene ontology analysis revealed that proteins related to vesicle trafficking, membrane transport, and many membrane proteins, including transferrin receptor 1 (TfR1), were enriched. Because TfR1 promotes cellular iron uptake and iron is a key factor involved in kidney fibrosis, we focused on TfR1 and confirmed that it interacts with ATRAP. In addition, our findings revealed that enhanced ATRAP expression decreased cell-surface TfR1 expression without altering the overall cellular TfR1 expression levels. Furthermore, enhanced ATRAP expression attenuated cellular iron levels. Together, our results highlight the role of ATRAP as a suppressor of TfR1 that functions by facilitating TfR1 internalization, which affects iron metabolism and oxidative stress signaling.

    DOI: 10.1038/s41598-022-22343-5

    PubMed

    researchmap

  • PAR3 restricts the expansion of neural precursor cells by regulating hedgehog signaling. 国際誌

    Tomonori Hirose, Yoshinobu Sugitani, Hidetake Kurihara, Hiromi Kazama, Chiho Kusaka, Tetsuo Noda, Hidehisa Takahashi, Shigeo Ohno

    Development (Cambridge, England)   2022年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    During brain development, neural precursor cells (NPCs) expand initially, and then switch to generating stage-specific neurons while maintaining self-renewal ability. Because the NPC pool at the onset of neurogenesis critically affects the final number of each type of neuron, tight regulation is necessary for the transitional timing from the expansion to neurogenic phase in these cells. However, the molecular mechanisms underlying this transition are poorly understood. Here, we report that the telencephalon-specific loss of PAR3 before the start of neurogenesis leads to increased NPC proliferation in dispense of neurogenesis, resulting in disorganized tissue architecture. These NPCs demonstrate hyperactivation of Hedgehog signaling in a Smoothened-dependent manner, as well as defects in primary cilia. Furthermore, loss of PAR3 enhanced ligand-independent ciliary accumulation of Smoothened and an inhibitor of Smoothened ameliorated the hyperproliferation of NPCs in the telencephalon. Thus, these findings support the idea that PAR3 has a critical role in the transition of NPCs from the expansion to neurogenic phase by restricting Hedgehog signaling through the establishment of ciliary integrity.

    DOI: 10.1242/dev.199931

    PubMed

    researchmap

  • Dual function of SF3B2 on chromatin and RNA to regulate transcription in head and neck squamous cell carcinoma. 国際誌

    Koji Kitamura, Hidefumi Suzuki, Ryota Abe, Hidenori Inohara, Yasufumi Kaneda, Hidehisa Takahashi, Keisuke Nimura

    Cell & bioscience   12 ( 1 )   92 - 92   2022年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    RNA is spliced concomitantly with transcription and the process is organized by RNA splicing factors, transcriptional regulators, and chromatin regulators. RNA is spliced in close proximity to transcription machinery. Hence, some RNA splicing factors may play a role in transcription. Here, we show that the splicing factor SF3B2 binds to gene regulatory elements and mRNA to modulate transcription and RNA stability in head and neck squamous cell carcinoma cells. High SF3B2 expression leads to poor prognosis in patients with head and neck squamous cell carcinoma and to progression of tumor growth in mice. SF3B2 promotes tumor growth, owing to its involvement in activation of gene expression associated with mitochondrial electron transport and transcription regulatory region DNA binding. SF3B2 is enriched around the promoter element on chromatin and the transcription termination site on RNA. SF3B2 is involved in the regulation of RNA stability. According to the SF3B2-binding profile, SF3B2 regulates RNA polymerase II activity, in addition to regulating RNA splicing. Mechanistically, SF3B2 promotes the binding of structural maintenance of chromosomes 1A and CCCTC-binding factor (CTCF) to the SF3B2-binding genomic regions. SF3B2 also modulates CTCF transcriptional activity. Our findings indicate that SF3B2 has a dual function in both transcription and RNA stability, leading to head and neck squamous cell carcinoma progression.

    DOI: 10.1186/s13578-022-00812-8

    PubMed

    researchmap

  • The 3' Pol II pausing at replication-dependent histone genes is regulated by Mediator through Cajal bodies' association with histone locus bodies. 国際誌

    Hidefumi Suzuki, Ryota Abe, Miho Shimada, Tomonori Hirose, Hiroko Hirose, Keisuke Noguchi, Yoko Ike, Nanami Yasui, Kazuki Furugori, Yuki Yamaguchi, Atsushi Toyoda, Yutaka Suzuki, Tatsuro Yamamoto, Noriko Saitoh, Shigeo Sato, Chieri Tomomori-Sato, Ronald C Conaway, Joan W Conaway, Hidehisa Takahashi

    Nature communications   13 ( 1 )   2905 - 2905   2022年5月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Non-polyadenylated mRNAs of replication-dependent histones (RDHs) are synthesized by RNA polymerase II (Pol II) at histone locus bodies (HLBs). HLBs frequently associate with Cajal bodies (CBs), in which 3'-end processing factors for RDH genes are enriched; however, this association's role in transcription termination of RDH genes remains unclear. Here, we show that Pol II pauses immediately upstream of transcript end sites of RDH genes and Mediator plays a role in this Pol II pausing through CBs' association with HLBs. Disruption of the Mediator docking site for Little elongation complex (LEC)-Cap binding complex (CBC)-Negative elongation factor (NELF), components of CBs, interferes with CBs' association with HLBs and 3' Pol II pausing, resulting in increased aberrant unprocessed RDH gene transcripts. Our findings suggest Mediator's involvement in CBs' association with HLBs to facilitate 3' Pol II pausing and subsequent 3'-end processing of RDH genes by supplying 3'-end processing factors.

    DOI: 10.1038/s41467-022-30632-w

    PubMed

    researchmap

  • The nuclear transcription factor, TAF7, is a cytoplasmic regulator of protein synthesis. 国際誌

    Dan Cheng, Kevin Semmens, Elizabeth McManus, Qingrong Chen, Daoud Meerzaman, Xiantao Wang, Markus Hafner, Brian A Lewis, Hidehisa Takahashi, Ballachanda N Devaiah, Anne Gegonne, Dinah S Singer

    Science advances   7 ( 50 )   eabi5751   2021年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    [Figure: see text].

    DOI: 10.1126/sciadv.abi5751

    PubMed

    researchmap

  • De novo ARF3 variants cause neurodevelopmental disorder with brain abnormality. 国際誌

    Masamune Sakamoto, Kazunori Sasaki, Atsushi Sugie, Yohei Nitta, Tetsuaki Kimura, Semra Gürsoy, Tayfun Cinleti, Mizue Iai, Toru Sengoku, Kazuhiro Ogata, Atsushi Suzuki, Nobuhiko Okamoto, Kazuhiro Iwama, Naomi Tsuchida, Yuri Uchiyama, Eriko Koshimizu, Atsushi Fujita, Kohei Hamanaka, Satoko Miyatake, Takeshi Mizuguchi, Masataka Taguri, Shuuichi Ito, Hidehisa Takahashi, Noriko Miyake, Naomichi Matsumoto

    Human molecular genetics   31 ( 1 )   69 - 81   2021年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    An optimal Golgi transport system is important for mammalian cells. The adenosine diphosphate (ADP) ribosylation factors (ARF) are key proteins for regulating cargo sorting at the Golgi network. In this family, ARF3 mainly works at the trans-Golgi network (TGN), and no ARF3-related phenotypes have yet been described in humans. We here report the clinical and genetic evaluations of two unrelated children with de novo pathogenic variants in the ARF3 gene: c.200A > T (p.Asp67Val) and c.296G > T (p.Arg99Leu). Although the affected individuals presented commonly with developmental delay, epilepsy, and brain abnormalities, there were differences in severity, clinical course, and brain lesions. In vitro subcellular localization assays revealed that the p.Arg99Leu mutant localized to Golgi apparatus, similar to the wild-type, whereas the p.Asp67Val mutant tended to show a disperse cytosolic pattern together with abnormally dispersed Golgi localization, similar to that observed in a known dominant negative variant (p.Thr31Asn). Pull-down assays revealed that the p.Asp67Val had a loss-of-function effect and the p.Arg99Leu variant had increased binding of the adaptor protein, Golgi-localized, γ-adaptin ear-containing, ARF-binding protein 1 (GGA1), supporting the gain of function. Furthermore, in vivo studies revealed that p.Asp67Val transfection led to lethality in flies. In contrast, flies expressing p.Arg99Leu had abnormal rough eye, as observed in the gain-of-function variant p.Gln71Leu. These data indicate that two ARF3 variants, the possibly loss-of-function p.Asp67Val and the gain-of-function p.Arg99Leu, both impair the Golgi transport system. Therefore, it may not be unreasonable that they showed different clinical features like diffuse brain atrophy (p.Asp67Val) and cerebellar hypoplasia (p.Arg99Leu).

    DOI: 10.1093/hmg/ddab224

    PubMed

    researchmap

  • De novo ATP1A3 variants cause polymicrogyria. 国際誌

    Satoko Miyatake, Mitsuhiro Kato, Takuma Kumamoto, Tomonori Hirose, Eriko Koshimizu, Takaaki Matsui, Hideyuki Takeuchi, Hiroshi Doi, Keisuke Hamada, Mitsuko Nakashima, Kazunori Sasaki, Akio Yamashita, Atsushi Takata, Kohei Hamanaka, Mai Satoh, Takabumi Miyama, Yuri Sonoda, Momoko Sasazuki, Hiroyuki Torisu, Toshiro Hara, Yasunari Sakai, Yushi Noguchi, Mazumi Miura, Yoko Nishimura, Kazuyuki Nakamura, Hideyuki Asai, Nodoka Hinokuma, Fuyuki Miya, Tatsuhiko Tsunoda, Masami Togawa, Yukihiro Ikeda, Nobusuke Kimura, Kaoru Amemiya, Asako Horino, Masataka Fukuoka, Hiroko Ikeda, Goni Merhav, Nina Ekhilevitch, Masaki Miura, Takeshi Mizuguchi, Noriko Miyake, Atsushi Suzuki, Shouichi Ohga, Hirotomo Saitsu, Hidehisa Takahashi, Fumiaki Tanaka, Kazuhiro Ogata, Chiaki Ohtaka-Maruyama, Naomichi Matsumoto

    Science advances   7 ( 13 )   2021年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Polymicrogyria is a common malformation of cortical development whose etiology remains elusive. We conducted whole-exome sequencing for 124 patients with polymicrogyria and identified de novo ATP1A3 variants in eight patients. Mutated ATP1A3 causes functional brain diseases, including alternating hemiplegia of childhood (AHC), rapid-onset dystonia parkinsonism (RDP), and cerebellar ataxia, areflexia, pes cavus, optic nerve atrophy, and sensorineural deafness (CAPOS). However, our patients showed no clinical features of AHC, RDP, or CAPOS and had a completely different phenotype: a severe form of polymicrogyria with epilepsy and developmental delay. Detected variants had different locations in ATP1A3 and different functional properties compared with AHC-, RDP-, or CAPOS-associated variants. In the developing cerebral cortex of mice, radial neuronal migration was impaired in neurons overexpressing the ATP1A3 variant of the most severe patients, suggesting that this variant is involved in cortical malformation pathogenesis. We propose a previously unidentified category of polymicrogyria associated with ATP1A3 abnormalities.

    DOI: 10.1126/sciadv.abd2368

    PubMed

    researchmap

  • De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy. 国際誌

    Toshiyuki Itai, Kohei Hamanaka, Kazunori Sasaki, Matias Wagner, Urania Kotzaeridou, Ines Brösse, Markus Ries, Yu Kobayashi, Jun Tohyama, Mitsuhiro Kato, Winnie P Ong, Hui B Chew, Kavitha Rethanavelu, Emmanuelle Ranza, Xavier Blanc, Yuri Uchiyama, Naomi Tsuchida, Atsushi Fujita, Yoshiteru Azuma, Eriko Koshimizu, Takeshi Mizuguchi, Atsushi Takata, Noriko Miyake, Hidehisa Takahashi, Etsuko Miyagi, Yoshinori Tsurusaki, Hiroshi Doi, Masataka Taguri, Stylianos E Antonarakis, Mitsuko Nakashima, Hirotomo Saitsu, Satoko Miyatake, Naomichi Matsumoto

    Human mutation   42 ( 1 )   66 - 76   2020年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    We report heterozygous CELF2 (NM_006561.3) variants in five unrelated individuals: Individuals 1-4 exhibited developmental and epileptic encephalopathy (DEE) and Individual 5 had intellectual disability and autistic features. CELF2 encodes a nucleocytoplasmic shuttling RNA-binding protein that has multiple roles in RNA processing and is involved in the embryonic development of the central nervous system and heart. Whole-exome sequencing identified the following CELF2 variants: two missense variants [c.1558C>T:p.(Pro520Ser) in unrelated Individuals 1 and 2, and c.1516C>G:p.(Arg506Gly) in Individual 3], one frameshift variant in Individual 4 that removed the last amino acid of CELF2 c.1562dup:p.(Tyr521Ter), possibly resulting in escape from nonsense-mediated mRNA decay (NMD), and one canonical splice site variant, c.272-1G>C in Individual 5, also probably leading to NMD. The identified variants in Individuals 1, 2, 4, and 5 were de novo, while the variant in Individual 3 was inherited from her mosaic mother. Notably, all identified variants, except for c.272-1G>C, were clustered within 20 amino acid residues of the C-terminus, which might be a nuclear localization signal. We demonstrated the extranuclear mislocalization of mutant CELF2 protein in cells transfected with mutant CELF2 complementary DNA plasmids. Our findings indicate that CELF2 variants that disrupt its nuclear localization are associated with DEE.

    DOI: 10.1002/humu.24130

    PubMed

    researchmap

  • A substrate-trapping strategy to find E3 ubiquitin ligase substrates identifies Parkin and TRIM28 targets. 国際誌

    Masashi Watanabe, Yasushi Saeki, Hidehisa Takahashi, Fumiaki Ohtake, Yukiko Yoshida, Yusuke Kasuga, Takeshi Kondo, Hiroaki Yaguchi, Masanobu Suzuki, Hiroki Ishida, Keiji Tanaka, Shigetsugu Hatakeyama

    Communications biology   3 ( 1 )   592 - 592   2020年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The identification of true substrates of an E3 ligase is biologically important but biochemically difficult. In recent years, several techniques for identifying substrates have been developed, but these approaches cannot exclude indirect ubiquitination or have other limitations. Here we develop an E3 ligase substrate-trapping strategy by fusing a tandem ubiquitin-binding entity (TUBE) with an anti-ubiquitin remnant antibody to effectively identify ubiquitinated substrates. We apply this method to one of the RBR-type ligases, Parkin, and to one of the RING-type ligases, TRIM28, and identify previously unknown substrates for TRIM28 including cyclin A2 and TFIIB. Furthermore, we find that TRIM28 promotes cyclin A2 ubiquitination and degradation at the G1/S phase and suppresses premature entry into S phase. Taken together, the results indicate that this method is a powerful tool for comprehensively identifying substrates of E3 ligases.

    DOI: 10.1038/s42003-020-01328-y

    PubMed

    researchmap

  • A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis. 国際誌

    Tadasuke Tsukiyama, Juqi Zou, Jihoon Kim, Shohei Ogamino, Yuki Shino, Takamasa Masuda, Alessandra Merenda, Masaki Matsumoto, Yoichiro Fujioka, Tomonori Hirose, Sayuri Terai, Hidehisa Takahashi, Tohru Ishitani, Keiichi I Nakayama, Yusuke Ohba, Bon-Kyoung Koo, Shigetsugu Hatakeyama

    Nature communications   11 ( 1 )   4586 - 4586   2020年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Frequent mutation of the tumour suppressor RNF43 is observed in many cancers, particularly colon malignancies. RNF43, an E3 ubiquitin ligase, negatively regulates Wnt signalling by inducing degradation of the Wnt receptor Frizzled. In this study, we discover that RNF43 activity requires phosphorylation at a triplet of conserved serines. This phospho-regulation of RNF43 is required for zebrafish development and growth of mouse intestinal organoids. Cancer-associated mutations that abrogate RNF43 phosphorylation cooperate with active Ras to promote tumorigenesis by abolishing the inhibitory function of RNF43 in Wnt signalling while maintaining its inhibitory function in p53 signalling. Our data suggest that RNF43 mutations cooperate with KRAS mutations to promote multi-step tumorigenesis via the Wnt-Ras-p53 axis in human colon cancers. Lastly, phosphomimetic substitutions of the serine trio restored the tumour suppressive activity of extracellular oncogenic mutants. Therefore, harnessing phospho-regulation of RNF43 might be a potential therapeutic strategy for tumours with RNF43 mutations.

    DOI: 10.1038/s41467-020-18257-3

    PubMed

    researchmap

  • Shank2 Binds to aPKC and Controls Tight Junction Formation with Rap1 Signaling during Establishment of Epithelial Cell Polarity. 査読 国際誌

    Kazunori Sasaki, Noriko Kojitani, Hiroko Hirose, Yohei Yoshihama, Hidefumi Suzuki, Miho Shimada, Ayumi Takayanagi, Akio Yamashita, Masa-Aki Nakaya, Hisashi Hirano, Hidehisa Takahashi, Shigeo Ohno

    Cell reports   31 ( 1 )   107407 - 107407   2020年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Epithelial cells establish apicobasal polarity by forming tight junctions (TJs) at the apical-lateral boundary, which play fundamental roles in physiological functions. An evolutionarily conserved atypical protein kinase C (aPKC)-partitioning defective (PAR) complex functions as a platform for TJ assembly during cell polarity establishment. However, how this complex converts the spatial cues into a subsequent active unit is unclear. Here, we identify an epithelial isoform of Shank2 as a mediator of the aPKC-PAR complex. Shank2 binds to and colocalizes with aPKC at apical junctional regions of polarized epithelial cells. Shank2 knockdown results in defects in TJ formation. Mechanistically, we find that the N-terminal SPN domain is required for the junctional localization of Shank2 and binds to the active form of Rap1 small GTPase, which is involved in TJ formation. Our findings suggest that a close physical and functional relationship between aPKC and Shank2-active Rap1 signaling serves as the platform for TJ assembly to regulate epithelial cell polarity.

    DOI: 10.1016/j.celrep.2020.02.088

    PubMed

    researchmap

  • The role of Mediator and Little Elongation Complex in transcription termination. 査読 国際誌

    Hidehisa Takahashi, Amol Ranjan, Shiyuan Chen, Hidefumi Suzuki, Mio Shibata, Tomonori Hirose, Hiroko Hirose, Kazunori Sasaki, Ryota Abe, Kai Chen, Yanfeng He, Ying Zhang, Ichigaku Takigawa, Tadasuke Tsukiyama, Masashi Watanabe, Satoshi Fujii, Midori Iida, Junichi Yamamoto, Yuki Yamaguchi, Yutaka Suzuki, Masaki Matsumoto, Keiichi I Nakayama, Michael P Washburn, Anita Saraf, Laurence Florens, Shigeo Sato, Chieri Tomomori-Sato, Ronald C Conaway, Joan W Conaway, Shigetsugu Hatakeyama

    Nature communications   11 ( 1 )   1063 - 1063   2020年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Mediator is a coregulatory complex that regulates transcription of Pol II-dependent genes. Previously, we showed that human Mediator subunit MED26 plays a role in the recruitment of Super Elongation Complex (SEC) or Little Elongation Complex (LEC) to regulate the expression of certain genes. MED26 plays a role in recruiting SEC to protein-coding genes including c-myc and LEC to small nuclear RNA (snRNA) genes. However, how MED26 engages SEC or LEC to regulate distinct genes is unclear. Here, we provide evidence that MED26 recruits LEC to modulate transcription termination of non-polyadenylated transcripts including snRNAs and mRNAs encoding replication-dependent histone (RDH) at Cajal bodies. Our findings indicate that LEC recruited by MED26 promotes efficient transcription termination by Pol II through interaction with CBC-ARS2 and NELF/DSIF, and promotes 3' end processing by enhancing recruitment of Integrator or Heat Labile Factor to snRNA or RDH genes, respectively.

    DOI: 10.1038/s41467-020-14849-1

    PubMed

    researchmap

  • Gain-of-Function MN1 Truncation Variants Cause a Recognizable Syndrome with Craniofacial and Brain Abnormalities. 査読 国際誌

    Noriko Miyake, Hidehisa Takahashi, Kazuyuki Nakamura, Bertrand Isidor, Yoko Hiraki, Eriko Koshimizu, Masaaki Shiina, Kazunori Sasaki, Hidefumi Suzuki, Ryota Abe, Yayoi Kimura, Tomoko Akiyama, Shin-Ichi Tomizawa, Tomonori Hirose, Kohei Hamanaka, Satoko Miyatake, Satomi Mitsuhashi, Takeshi Mizuguchi, Atsushi Takata, Kazuyuki Obo, Mitsuhiro Kato, Kazuhiro Ogata, Naomichi Matsumoto

    American journal of human genetics   106 ( 1 )   13 - 25   2020年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    MN1 was originally identified as a tumor-suppressor gene. Knockout mouse studies have suggested that Mn1 is associated with craniofacial development. However, no MN1-related phenotypes have been established in humans. Here, we report on three individuals who have de novo MN1 variants that lead to a protein lacking the carboxyl (C) terminus and who presented with severe developmental delay, craniofacial abnormalities with specific facial features, and structural abnormalities in the brain. An in vitro study revealed that the deletion of the C-terminal region led to increased protein stability, an inhibitory effect on cell proliferation, and enhanced MN1 aggregation in nuclei compared to what occurred in the wild type, suggesting that a gain-of-function mechanism is involved in this disease. Considering that C-terminal deletion increases the fraction of intrinsically disordered regions of MN1, it is possible that altered phase separation could be involved in the mechanism underlying the disease. Our data indicate that MN1 participates in transcriptional regulation of target genes through interaction with the transcription factors PBX1, PKNOX1, and ZBTB24 and that mutant MN1 impairs the binding with ZBTB24 and RING1, which is an E3 ubiquitin ligase. On the basis of our findings, we propose the model that C-terminal deletion interferes with MN1's interaction molecules related to the ubiquitin-mediated proteasome pathway, including RING1, and increases the amount of the mutant protein; this increase leads to the dysregulation of MN1 target genes by inhibiting rapid MN1 protein turnover.

    DOI: 10.1016/j.ajhg.2019.11.011

    PubMed

    researchmap

  • NONO Is a Negative Regulator of SOX2 Promoter 査読

    SHANSHAN LIANG, HIDEHISA TAKAHASHI, TETSURO HIROSE, YASUHIRO KURAMITSU, SHIGETSUGU HATAKEYAMA, HIRONORI YOSHIYAMA, RUOYU WANG, JUN-ICHI HAMADA, HISASHI IIZASA

    Cancer Genomics - Proteomics   17 ( 4 )   359 - 367   2020年

     詳細を見る

    掲載種別:研究論文(学術雑誌)   出版者・発行元:Anticancer Research USA Inc.  

    DOI: 10.21873/cgp.20195

    researchmap

  • Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells. 国際誌

    Nanumi Han, Delnur Anwar, Naoki Hama, Takuto Kobayashi, Hidefumi Suzuki, Hidehisa Takahashi, Haruka Wada, Ryo Otsuka, Muhammad Baghdadi, Ken-Ichiro Seino

    Inflammation and regeneration   40   25 - 25   2020年

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Background: Interleukin (IL)-34 acts as an alternative ligand for the colony-stimulating factor-1 receptor and controls the biology of myeloid cells, including survival, proliferation, and differentiation. IL-34 has been reported to be expressed in cancer cells and to promote tumor progression and metastasis of certain cancers via the promotion of angiogenesis and immunosuppressive macrophage differentiation. We have shown in our previous reports that targeting IL-34 in chemo-resistant tumors in vitro resulted in a remarkable inhibition of tumor growth. Also, we reported poor prognosis in patients with IL-34-expressing tumor. Therefore, blocking of IL-34 is considered as a promising therapeutic strategy to suppress tumor progression. However, the molecular mechanisms that control IL-34 production are still largely unknown. Methods: IL-34 producing ovarian cancer cell line HM-1 was treated by bromodomain and extra terminal inhibitor JQ1. The mRNA and protein expression of IL-34 was evaluated after JQ1 treatment. Chromatin immunoprecipitation was performed to confirm the involvement of bromodomain-containing protein 4 (Brd4) in the regulation of the Il34 gene. Anti-tumor effect of JQ1 was evaluated in mouse tumor model. Results: We identified Brd4 as one of the critical molecules that regulate Il34 expression in cancer cells. Consistent with this, we found that JQ1 is capable of efficiently suppressing the recruitment of Brd4 to the promotor region of Il34 gene. Additionally, JQ1 treatment of mice bearing IL-34-producing tumor inhibited the tumor growth along with decreasing Il34 expression in the tumor. Conclusion: The results unveiled for the first time the responsible molecule Brd4 that regulates Il34 expression in cancer cells and suggested its possibility as a treatment target.

    DOI: 10.1186/s41232-020-00129-4

    PubMed

    researchmap

  • Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line. 査読 国際誌

    Takahiro Yamaji, Akio Yamashita, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, Yumiko Fujikawa, Sona Haku, Ryu Kobayashi, Kohji Ohki, Kotaro Haruhara, Sho Kinguchi, Takeo Ishii, Takayuki Yamada, Shingo Urate, Toru Suzuki, Eriko Abe, Shohei Tanaka, Daisuke Kamimura, Tomoaki Ishigami, Yoshiyuki Toya, Hidehisa Takahashi, Kouichi Tamura

    Scientific reports   9 ( 1 )   16550 - 16550   2019年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    The proximal tubule is a particularly important site for ageing-related kidney damage. Sirtuin 1 (SIRT1), an NAD+ (nicotinamide adenine dinucleotide)-dependent deacetylase in the proximal tubule, may be involved in renal injury associated with ageing. However, the mechanisms of SIRT1 regulation remain to be elucidated. We recently reported that angiotensin II type 1 receptor (AT1R)-associated protein (ATRAP)-deficient mice displayed age-associated renal function decline and tubulointerstitial fibrosis. Our data showed that SIRT1 protein expression was reduced in ATRAP-deficient mice, although the relationship between ATRAP deficiency and age-associated renal fibrosis is still not fully understood. It is, therefore, necessary to investigate how ATRAP affects SIRT1 protein expression to resolve ageing-associated kidney dysfunction. Here, since ageing studies are inherently lengthy, we used an ex vivo model of the proximal tubule to determine the role of ATRAP in SIRT1 protein expression. We first generated a clonal immortalised human renal proximal tubule epithelial cell line (ciRPTEC) expressing AT1R and ATRAP. Using this cell line, we demonstrated that ATRAP knockdown reduced SIRT1 protein expression in the ciRPTEC but did not alter SIRT1 mRNA expression. Thus, ATRAP likely mediates SIRT1 protein abundance in ciRPTEC.

    DOI: 10.1038/s41598-019-52566-y

    PubMed

    researchmap

  • Loss of TRIM29 alters keratin distribution to promote cell invasion in squamous cell carcinoma. 査読 国際誌

    Yanagi T, Watanabe M, Hata H, Kitamura S, Imafuku K, Yanagi H, Homma A, Wang L, Takahashi H, Shimizu H, Hatakeyama S

    Cancer research   78 ( 24 )   6795 - 6806   2018年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1158/0008-5472.CAN-18-1495

    PubMed

    researchmap

  • Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure. 査読 国際誌

    Junichi Matsumoto, Shingo Takada, Shintaro Kinugawa, Takaaki Furihata, Hideo Nambu, Naoya Kakutani, Masaya Tsuda, Arata Fukushima, Takashi Yokota, Shinya Tanaka, Hidehisa Takahashi, Masashi Watanabe, Shigetsugu Hatakeyama, Masaki Matsumoto, Keiichi I Nakayama, Yutaro Otsuka, Hisataka Sabe, Hiroyuki Tsutsui, Toshihisa Anzai

    Circulation   138 ( 18 )   2064 - 2066   2018年10月

     詳細を見る

  • Anti-Sez6l2 antibody detected in a patient with immune-mediated cerebellar ataxia inhibits complex formation of GluR1 and Sez6l2 査読

    Hiroaki Yaguchi, Ichiro Yabe, Hidehisa Takahashi, Masashi Watanabe, Taichi Nomura, Takahiro Kano, Masahiko Watanabe, Shigetsugu Hatakeyama

    Journal of Neurology   265 ( 4 )   962 - 965   2018年4月

     詳細を見る

    記述言語:英語   出版者・発行元:Dr. Dietrich Steinkopff Verlag GmbH and Co. KG  

    DOI: 10.1007/s00415-018-8785-z

    Scopus

    PubMed

    researchmap

  • Mutations in bassoon in individuals with familial and sporadic progressive supranuclear palsy-like syndrome. 査読 国際誌

    Ichiro Yabe, Hiroaki Yaguchi, Yasutaka Kato, Yasuo Miki, Hidehisa Takahashi, Satoshi Tanikawa, Shinichi Shirai, Ikuko Takahashi, Mari Kimura, Yuka Hama, Masaaki Matsushima, Shinsuke Fujioka, Takahiro Kano, Masashi Watanabe, Shin Nakagawa, Yasuyuki Kunieda, Yoshio Ikeda, Masato Hasegawa, Hiroshi Nishihara, Toshihisa Ohtsuka, Shinya Tanaka, Yoshio Tsuboi, Shigetsugu Hatakeyama, Koichi Wakabayashi, Hidenao Sasaki

    Scientific reports   8 ( 1 )   819 - 819   2018年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    Clinical diagnosis of progressive supranuclear palsy (PSP) is sometimes difficult because various phenotypes have been identified. Here, we report a mutation in the bassoon (BSN) gene in a family with PSP-like syndrome. Their clinical features resembled not only those of PSP patients but also those of individuals with multiple system atrophy and Alzheimer's disease. The neuropathological findings showed a novel three + four repeat tauopathy with pallido-luysio-nigral degeneration and hippocampal sclerosis. Whole-exome analysis of this family identified a novel missense mutation in BSN. Within the pedigree, the detected BSN mutation was found only in affected individuals. Further genetic analyses were conducted in probands from four other pedigrees with PSP-like syndrome and in 41 sporadic cases. Three missense mutations in BSN that are very rarely listed in databases of healthy subjects were found in four sporadic cases. Western blot analysis of tau following the overexpression of wild-type or mutated BSN revealed the possibility that wild-type BSN reduced tau accumulation, while mutated BSN lost this function. An association between BSN and neurological diseases has not been previously reported. Our results revealed that the neurodegenerative disorder associated with the original proband's pedigree is a novel tauopathy, differing from known dementia and parkinsonism syndromes, including PSP.

    DOI: 10.1038/s41598-018-19198-0

    PubMed

    researchmap

  • Sez6l2 regulates phosphorylation of ADD and neuritogenesis 査読

    Hiroaki Yaguchi, Ichiro Yabe, Hidehisa Takahashi, Masashi Watanabe, Taichi Nomura, Takahiro Kano, Masaki Matsumoto, Keiichi I. Nakayama, Masahiko Watanabe, Shigetsugu Hatakeyama

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   494 ( 1-2 )   234 - 241   2017年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ACADEMIC PRESS INC ELSEVIER SCIENCE  

    Increasing evidence shows that immune-mediated mechanisms may contribute to the pathogenesis of central nervous system disorders including cerebellar ataxias, as indicated by the aberrant production of neuronal surface antibodies. We previously reported a patient with cerebellar ataxia associated with production of a new anti-neuronal antibody, anti-seizure-related 6 homolog like 2 (Sez6l2). Sez6l2 is a type 1 membrane protein that is highly expressed in the hippocampus and cerebellar cortex and mice lacking Sez6l2 protein family members develop ataxia. Here we used a proteomics-based approach to show that serum derived from this patient recognizes the extracellular domain of Sez6l2 and that Sez6l2 protein binds to both adducin (ADD) and glutamate receptor 1 (GluR1). Our results indicate that Sez6l2 is one of the auxiliary subunits of the AMPA receptor and acts as a scaffolding protein to link GluR1 to ADD. Furthermore, Sez6l2 overexpression upregulates ADD phosphorylation, whereas siRNA-mediated downregulation of Sez6l2 prevents ADD phosphorylation, suggesting that Sez6l2 modulates AMPAADD signal transduction. (C) 2017 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2017.10.047

    Web of Science

    PubMed

    researchmap

  • The novel heart-specific RING finger protein 207 is involved in energy metabolism in cardiomyocytes 査読

    Wataru Mizushima, Hidehisa Takahashi, Masashi Watanabe, Shintaro Kinugawa, Shouji Matsushima, Shingo Takada, Takashi Yokota, Takaaki Furihata, Junichi Matsumoto, Masaya Tsuda, Ikuru Chiba, Shun Nagashima, Shigeru Yanagi, Masaki Matsumoto, Keiichi I. Nakayama, Hiroyuki Tsutsui, Shigetsugu Hatakeyama

    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY   100   43 - 53   2016年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCI LTD  

    A failing heart shows severe energy insufficiency, and it is presumed that this energy shortage plays a critical role in the development of cardiac dysfunction. However, little is known about the mechanisms that cause energy metabolic alterations in the failing heart. Here, we show that the novel RING-finger protein 207 (RNF207), which is specifically expressed in the heart, plays a role in cardiac energy metabolism. Depletion of RNF207 in neonatal rat cardiomyocytes (NRCs) leads to a reduced cellular concentration of adenosine triphosphate (ATP) and mitochondrial dysfunction. Consistent with this result, we observed here that the expression of RNF207 was significantly reduced in mice with common cardiac diseases including heart failure. Intriguingly, proteomic approaches revealed that RNF207 interacts with the voltage-dependent anion channel (VDAC), which is considered to be a key regulator of mitochondria function, as an RNF207-interacting protein. Our findings indicate that RNF207 is involved in ATP production by cardiomyocytes, suggesting that RNF207 plays an important role in the development of heart failure. (C) 2016 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.yjmcc.2016.09.013

    Web of Science

    PubMed

    researchmap

  • p53 represses the transcription of snRNA genes by preventing the formation of little elongation complex 査読

    Delnur Anwar, Hidehisa Takahashi, Masashi Watanabe, Masanobu Suzuki, Satoshi Fukuda, Shigetsugu Hatakeyama

    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS   1859 ( 8 )   975 - 982   2016年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    The regulation of transcription by RNA polymerase II (Pol II) is important for a variety of cellular functions. ELL/EAF-containing little elongation complex (LEC) was found to be required for transcription of Pol II-dependent small nuclear RNA (snRNA) genes. It was shown that the tumor suppressor p53 interacts with ELL and inhibits transcription elongation activity of ELL Here, we show that p53 inhibits interaction between ELL/EAF and ICE1 in LEC and thereby p53 represses transcription of Pol II-dependent snRNA genes through inhibiting LEC function. Furthermore, induction of p53 expression by ultraviolet (UV) irradiation decreases the occupancy of ICE1 at Pol II-dependent snRNA genes. Consistent with the results, knockdown of p53 increased both the expression of snRNA genes and the occupancy of Pol II and components of LEC at snRNA genes. Our results indicate that p53 interferes with the interaction between ELL/EAF and ICE1 and represses transcription of snRNA genes by Pol II. (C) 2016 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.bbagrm.2016.06.001

    Web of Science

    researchmap

  • p53 represses the transcription of snRNA genes by preventing the formation of little elongation complex. 査読

    Anwar D, Takahashi H, Watanabe M, Suzuki M, Fukuda S, Hatakeyama S

    Biochimica et biophysica acta   1859 ( 8 )   975 - 982   2016年8月

  • Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes 査読

    Yuichiro Fujieda, Olga Amengual, Masaki Matsumoto, Kimiko Kuroki, Hidehisa Takahashi, Michihito Kono, Takashi Kurita, Kotaro Otomo, Masaru Kato, Kenji Oku, Toshiyuki Bohgaki, Tetsuya Horita, Shinsuke Yasuda, Katsumi Maenaka, Shigetsugu Hatakeyama, Keiichi I. Nakayama, Tatsuya Atsumi

    RHEUMATOLOGY   55 ( 6 )   1117 - 1126   2016年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:OXFORD UNIV PRESS  

    Objective. Phosphatidylserine-dependent, also called aPS-PT, recognizes the phosphati dylserine-prothrombin complex, which is associated with APS. We have previously reported that aPS-PT induces tissue factor (TF) expression on monocytes through the p38 mitogen-activated protein kinase pathway. However, the cell surface interaction between prothrombin and aPS-PT, which is involved in the activation of cell-signalling pathways, has remained unknown. The objective of this study was to identify membrane proteins involved in the binding of prothrombin and aPS-PT to monocyte surfaces as well as the induction of TF expression.
    Methods. RAW264.7 cells with FLAG-tagged prothrombin were incubated and separated using affinity chromatography with anti-FLAG antibody-conjugated Sepharose beads. Immunopurified proteins were then analysed by an online nano-liquid chromatography-tandem mass spectrometry. The binding between prothrombin and the identified protein, ribophorin II (RPN2), was analysed by ELISA and surface plasmon resonance. To elucidate the role of RPN2 in TF expression, the TF mRNA level in RAW264.7 cells treated with RPN2 small interfering RNA was determined by quantitative real-time PCR (qPCR).
    Results. RPN2 was identified as a candidate molecule involved in the binding of prothrombin to the cell surface. The binding between prothrombin and RPN2 was confirmed by ELISA and surface plasmon resonance. RAW264.7 cells treated with RPN2 small interfering RNA showed significant reduction of the TF expression mediated by prothrombin and a mouse monoclonal aPS-PT.
    Conclusion. We identified that RPN2 is one of the prothrombin-binding proteins on monocyte surfaces, suggesting that RPN2 is involved in the pathophysiology of thrombosis in patients with APS.

    DOI: 10.1093/rheumatology/kew005

    Web of Science

    PubMed

    researchmap

  • TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin. 査読

    Suzuki M, Watanabe M, Nakamaru Y, Takagi D, Takahashi H, Fukuda S, Hatakeyama S

    Cellular and molecular life sciences : CMLS   73 ( 5 )   1085 - 1101   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.1007/s00018-015-2040-x

    Web of Science

    PubMed

    researchmap

  • Chd5 Regulates MuERV-L/MERVL Expression in Mouse Embryonic Stem Cells Via H3K27me3 Modification and Histone H3.1/H3.2 査読

    Masayasu Hayashi, Kazumitsu Maehara, Akihito Harada, Yuichiro Semba, Kensuke Kudo, Hidehisa Takahashi, Shinya Oki, Chikara Meno, Kenji Ichiyanagi, Koichi Akashi, Yasuyuki Ohkawa

    JOURNAL OF CELLULAR BIOCHEMISTRY   117 ( 3 )   780 - 792   2016年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY  

    Chd5 is an essential factor for neuronal differentiation and spermatogenesis and is a known tumor suppressor. H3K27me3 and H3K4un are modifications recognized by Chd5; however, it remains unclear how Chd5 remodels chromatin structure. We completely disrupted the Chd5 locus using the CRISPR-Cas9 system to generate a 52 kbp long deletion and analyzed Chd5 function in mouse embryonic stem cells. Our findings show that Chd5 represses murine endogenous retrovirus-L (MuERV-L/MERVL), an endogenous retrovirus-derived retrotransposon, by regulating H3K27me3 and H3.1/H3.2 function. (C) 2015 Wiley Periodicals, Inc.

    DOI: 10.1002/jcb.25368

    Web of Science

    PubMed

    researchmap

  • TRIM29 regulates the p63-mediated pathway in cervical cancer cells 査読

    Yasushi Masuda, Hidehisa Takahashi, Shigetsugu Hatakeyama

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH   1853 ( 10 )   2296 - 2305   2015年10月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    Cell invasion and adhesion play an important role in cancer metastasis and are orchestrated by a complicated network of transcription factors including p63. Here, we show that a member of the tripartite motif protein family, TRIM29, is required for regulation of the p63-mediated pathway in cervical cancer cells. TRIM29 knockdown alters the adhesion and invasion activities of cervical cancer cells. TRIM29 knockdown and overexpression cause a significant decrease and increase of TAp63 alpha expression, respectively. TRIM29 knockdown alters the expression pattern of integrins and increases ZEB1 expression. TRIM29 is required for suppression of an increase in the adhesion activity of cells by TAp63 alpha. These findings suggest that TRIM29 regulates the p63-mediated pathway and the behavior of cervical cancer cells. (C) 2015 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.bbamcr.2015.05.035

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • TRIM29 regulates the p63-mediated pathway in cervical cancer cells. 査読

    Masuda Y, Takahashi H, Hatakeyama S

    Biochimica et biophysica acta   1853 ( 10 Pt A )   2296 - 2305   2015年6月

  • TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin 査読

    Yasushi Masuda, Hidehisa Takahashi, Shigeo Sato, Chieri Tomomori-Sato, Anita Saraf, Michael P. Washburn, Laurence Florens, Ronald C. Conaway, Joan W. Conaway, Shigetsugu Hatakeyama

    NATURE COMMUNICATIONS   6   7299   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Although DNA double-strand break (DSB) repair is mediated by numerous proteins accumulated at DSB sites, how DNA repair proteins are assembled into damaged chromatin has not been fully elucidated. Here we show that a member of the tripartite motif protein family, TRIM29, is a histone-binding protein responsible for DNA damage response (DDR). We found that TRIM29 interacts with BRCA1-associated surveillance complex, cohesion, DNA-PKcs and components of TIP60 complex. The dynamics of the TRIM29-containing complex on H2AX nucleosomes is coordinated by a cross-talk between histone modifications. TRIM29 binds to modified histone H3 and H4 tails in the context of nucleosomes. Furthermore, chromatin binding of TRIM29 is required for the phosphorylation of H2AX and cell viability in response to ionizing radiation. Our results suggest that TRIM29 functions as a scaffold protein to assemble DNA repair proteins into chromatin followed by efficient activation of DDR.

    DOI: 10.1038/ncomms8299

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling 査読

    Tadasuke Tsukiyama, Akimasa Fukui, Sayuri Terai, Yoichiro Fujioka, Keisuke Shinada, Hidehisa Takahashi, Terry P. Yamaguchi, Yusuke Ohba, Shigetsugu Hatakeyama

    MOLECULAR AND CELLULAR BIOLOGY   35 ( 11 )   2007 - 2023   2015年6月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    Wnt signaling pathways are tightly regulated by ubiquitination, and dysregulation of these pathways promotes tumorigenesis. It has been reported that the ubiquitin ligase RNF43 plays an important role in frizzled-dependent regulation of the Wnt/beta-catenin pathway. Here, we show that RNF43 suppresses both Wnt/beta-catenin signaling and noncanonical Wnt signaling by distinct mechanisms. The suppression of Wnt/beta-catenin signaling requires interaction between the extracellular protease-associated (PA) domain and the cysteine-rich domain (CRD) of frizzled and the intracellular RING finger domain of RNF43. In contrast, these N-terminal domains of RNF43 are not required for inhibition of noncanonical Wnt signaling, but interaction between the C-terminal cytoplasmic region of RNF43 and the PDZ domain of dishevelled is essential for this suppression. We further show the mechanism by which missense mutations in the extracellular portion of RNF43 identified in patients with tumors activate Wnt/beta-catenin signaling. Missense mutations of RNF43 change their localization from the endosome to the endoplasmic reticulum (ER), resulting in the failure of frizzled-dependent suppression of Wnt/beta-catenin signaling. However, these mutants retain the ability to suppress noncanonical Wnt signaling, probably due to interaction with dishevelled. RNF43 is also one of the potential target genes of Wnt/beta-catenin signaling. Our results reveal the molecular role of RNF43 and provide an insight into tumorigenesis.

    DOI: 10.1128/MCB.00159-15

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • The E3 ubiquitin ligase TRIM23 regulates adipocyte differentiation via stabilization of the adipogenic activator PPARγ. 査読

    Watanabe M, Takahashi H, Saeki Y, Ozaki T, Itoh S, Suzuki M, Mizushima W, Tanaka K, Hatakeyama S

    eLife   4   e05615   2015年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)  

    DOI: 10.7554/eLife.05615

    Web of Science

    PubMed

    researchmap

  • The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway 査読

    T. Sato, H. Takahashi, S. Hatakeyama, A. Iguchi, T. Ariga

    ONCOGENE   34 ( 10 )   1280 - 1291   2015年3月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    The receptor for activated C-kinase (RACK1), a scaffolding protein that participates in the protein kinase C (PKC) signaling pathway, has an important role in shuttling active PKCs to its substrate. Indeed, recent studies have revealed that RACK1 has an important role in tumorigenesis and that enhancement of the feed-forward mechanism of the c-Jun N-terminal kinase (JNK)-Jun pathway via RACK1 is associated with constitutive activation of MEK (MAPK-ERK kinase)-ERK (extracellular signal-regulated kinase) signaling in human melanoma cells. Taken together, RACK1 additionally has a very important role in the mitogen-activated protein kinase (MAPK) signaling pathway. Here, we show that one of the tripartite motif-containing (TRIM) family ubiquitin ligases, TRIM45, is a novel RACK1-interacting protein and downregulates MAPK signal transduction. Importantly, the expression of TRIM45 is induced when growth-promoting extracellular stimuli activate the MAPK signaling pathway, resulting in attenuation of activation of the MAPK pathway. These findings suggest that TRIM45 functions as a member of the negative feedback loop of the MAPK pathway.

    DOI: 10.1038/onc.2014.68

    Web of Science

    PubMed

    researchmap

  • MED26 regulates the transcription of snRNA genes through the recruitment of little elongation complex 査読

    Hidehisa Takahashi, Ichigaku Takigawa, Masashi Watanabe, Delnur Anwar, Mio Shibata, Chieri Tomomori-Sato, Shigeo Sato, Amol Ranjan, Chris W. Seidel, Tadasuke Tsukiyama, Wataru Mizushima, Masayasu Hayashi, Yasuyuki Ohkawa, Joan W. Conaway, Ronald C. Conaway, Shigetsugu Hatakeyama

    NATURE COMMUNICATIONS   6   5941   2015年1月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:NATURE PUBLISHING GROUP  

    Regulation of transcription elongation by RNA polymerase II (Pol II) is a key regulatory step in gene transcription. Recently, the little elongation complex (LEC)-which contains the transcription elongation factor ELL/EAF-was found to be required for the transcription of Pol II-dependent small nuclear RNA (snRNA) genes. Here we show that the human Mediator subunit MED26 plays a role in the recruitment of LEC to a subset of snRNA genes through direct interaction of EAF and the N-terminal domain (NTD) of MED26. Loss of MED26 in cells decreases the occupancy of LEC at a subset of snRNA genes and results in a reduction in their transcription. Our results suggest that the MED26-NTD functions as a molecular switch in the exchange of TBP-associated factor 7 (TAF7) for LEC to facilitate the transition from initiation to elongation during transcription of a subset of snRNA genes.

    DOI: 10.1038/ncomms6941

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Pathology of frontotemporal dementia with limb girdle muscular dystrophy caused by a DNAJB6 mutation 査読

    Ichiro Yabe, Mishie Tanino, Hiroaki Yaguchi, Akihiro Takiyama, Huaying Cai, Hiromi Kanno, Ikuko Takahashi, Yukiko K. Hayashi, Masashi Watanabe, Hidehisa Takahashi, Shigetsugu Hatakeyama, Shinya Tanak, Hidenao Sasaki

    CLINICAL NEUROLOGY AND NEUROSURGERY   127   10 - 12   2014年12月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:ELSEVIER SCIENCE BV  

    DOI: 10.1016/j.clineuro.2014.09.013

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Identification of anti-Sez612 antibody in a patient with cerebellar ataxia and retinopathy 査読

    Hiroaki Yaguchi, Ichiro Yabe, Hidehisa Takahashi, Fumihiko Okumura, Akiko Takeuchi, Kazuhiro Horiuchi, Takahiro Kano, Atsuhiro Kanda, Wataru Saito, Masaki Matsumoto, Keiichi I. Nakayama, Shigetsugu Hatakeyama, Hidenao Sasaki

    JOURNAL OF NEUROLOGY   261 ( 1 )   224 - 226   2014年1月

     詳細を見る

    記述言語:英語   出版者・発行元:SPRINGER HEIDELBERG  

    DOI: 10.1007/s00415-013-7134-5

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Transcriptional Elongation Factor Elongin A Regulates Retinoic Acid-Induced Gene Expression during Neuronal Differentiation 査読

    Takashi Yasukawa, Shachi Bhatt, Tamotsu Takeuchi, Junya Kawauchi, Hidehisa Takahashi, Aya Tsutsui, Takuya Muraoka, Makoto Inoue, Masayuki Tsuda, Shigetaka Kitajima, Ronald C. Conaway, Joan W. Conaway, Paul A. Trainor, Teijiro Aso

    CELL REPORTS   2 ( 5 )   1129 - 1136   2012年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Elongin A increases the rate of RNA polymerase II (pol II) transcript elongation by suppressing transient pausing by the enzyme. Elongin A also acts as a component of a cullin-RING ligase that can target stalled pol II for ubiquitylation and proteasome-dependent degradation. It is not known whether these activities of Elongin A are functionally interdependent in vivo. Here, we demonstrate that Elongin A-deficient (Elongin A(-/-)) embryos exhibit abnormalities in the formation of both cranial and spinal nerves and that Elongin A(-/-) embryonic stem cells (ESCs) show a markedly decreased capacity to differentiate into neurons. Moreover, we identify Elongin A mutations that selectively inactivate one or the other of the aforementioned activities and show that mutants that retain the elongation stimulatory, but not pol II ubiquitylation, activity of Elongin A rescue neuronal differentiation and support retinoic acid-induced upregulation of a subset of neurogenesis-related genes in Elongin A(-/-) ESCs.

    DOI: 10.1016/j.celrep.2012.09.031

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • TRIM67 Protein Negatively Regulates Ras Activity through Degradation of 80K-H and Induces Neuritogenesis 査読

    Hiroaki Yaguchi, Fumihiko Okumura, Hidehisa Takahashi, Takahiro Kano, Hiroyuki Kameda, Motokazu Uchigashima, Shinya Tanaka, Masahiko Watanabe, Hidenao Sasaki, Shigetsugu Hatakeyama

    JOURNAL OF BIOLOGICAL CHEMISTRY   287 ( 15 )   12050 - 12059   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Tripartite motif (TRIM)-containing proteins, which are defined by the presence of a common domain structure composed of a RING finger, one or two B-box motifs and a coiled-coil motif, are involved in many biological processes including innate immunity, viral infection, carcinogenesis, and development. Here we show that TRIM67, which has a TRIM motif, an FN3 domain and a SPRY domain, is highly expressed in the cerebellum and that TRIM67 interacts with PRG-1 and 80K-H, which is involved in the Ras-mediated signaling pathway. Ectopic expression of TRIM67 results in degradation of endogenous 80K-H and attenuation of cell proliferation and enhances neuritogenesis in the neuroblastoma cell line N1E-115. Furthermore, morphological and biological changes caused by knockdown of 80K-H are similar to those observed by overexpression of TRIM67. These findings suggest that TRIM67 regulates Ras signaling via degradation of 80K-H, leading to neural differentiation including neuritogenesis.

    DOI: 10.1074/jbc.M111.307678

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Role for the human Mediator subunit Med26 in transcription elongation 査読

    Hidehisa Takahasht

    Seikagaku   84 ( 7 )   577 - 581   2012年

     詳細を見る

    記述言語:日本語  

    Scopus

    PubMed

    researchmap

  • Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors 査読

    Hidehisa Takahashi, Tari J. Parmely, Shigeo Sato, Chieri Tomomori-Sato, Charles A. S. Banks, Stephanie E. Kong, Henrietta Szutorisz, Selene K. Swanson, Skylar Martin-Brown, Michael P. Washburn, Laurence Florens, Chris W. Seidel, Chengqi Lin, Edwin R. Smith, Ali Shilatifard, Ronald C. Conaway, Joan W. Conaway

    CELL   146 ( 1 )   92 - 104   2011年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Promoter-proximal pausing by initiated RNA polymerase II (Pol II) and regulated release of paused polymerase into productive elongation has emerged as a major mechanism of transcription activation. Reactivation of paused Pol II correlates with recruitment of super-elongation complexes (SECs) containing ELL/EAF family members, P-TEFb, and other proteins, but the mechanism of their recruitment is an unanswered question. Here, we present evidence for a role of human Mediator subunit MED26 in this process. We identify in the conserved N-terminal domain of MED26 overlapping docking sites for SEC and a second ELL/EAF-containing complex, as well as general initiation factor TFIID. In addition, we present evidence consistent with the model that MED26 can function as a molecular switch that interacts first with TFIID in the Pol II initiation complex and then exchanges TFIID for complexes containing ELL/EAF and P-TEFb to facilitate transition of Pol II into the elongation stage of transcription.

    DOI: 10.1016/j.cell.2011.06.005

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • AFF4, a Component of the ELL/P-TEFb Elongation Complex and a Shared Subunit of MLL Chimeras, Can Link Transcription Elongation to Leukemia 査読

    Chengqi Lin, Edwin R. Smith, Hidehisa Takahashi, Ka Chun Lai, Skylar Martin-Brown, Laurence Florens, Michael P. Washburn, Joan W. Conaway, Ronald C. Conaway, Ali Shilatifard

    MOLECULAR CELL   37 ( 3 )   429 - 437   2010年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Chromosomal translocations; involving the MLL gene are associated with infant acute lymphoblastic and mixed lineage leukemia. There are a large number of translocation partners of MLL that share very little sequence or seemingly functional similarities; however, their translocations into MLL result in the pathogenesis of leukemia. To define the molecular reason why these translocations result in the pathogenesis of leukemia, we purified several of the commonly occurring MILL chimeras. We have identified super elongation complex (SEC) associated with all chimeras purified. SEC includes ELL, P-TEFb, AFF4, and several other factors. AFF4 is required for SEC stability and proper transcription by poised RNA polymerase II in metazoans. Knockdown of AFF4 in leukemic cells shows reduction in MLL chimera target gene expression, suggesting that AFF4/SEC could be a key regulator in the pathogenesis of leukemia through many of the MILL partners.

    DOI: 10.1016/j.molcel.2010.01.026

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Proteomics Reveals a Physical and Functional Link between Hepatocyte Nuclear Factor 4 alpha and Transcription Factor IID 査読

    Hidehisa Takahashi, Skylar Martin-Brown, Michael P. Washburn, Laurence Florens, Joan W. Conaway, Ronald C. Conaway

    JOURNAL OF BIOLOGICAL CHEMISTRY   284 ( 47 )   32405 - 32412   2009年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    Proteomic analyses have contributed substantially to our understanding of diverse cellular processes. Improvements in the sensitivity of mass spectrometry approaches are enabling more in-depth analyses of protein-protein networks and, in some cases, are providing surprising new insights into well established, longstanding problems. Here, we describe such a proteomic analysis that exploits MudPIT mass spectrometry and has led to the discovery of a physical and functional link between the orphan nuclear receptor hepatocyte nuclear factor 4 alpha (HNF4 alpha) and transcription factor IID (TFIID). A systematic characterization of the HNF4 alpha-TFIID link revealed that the HNF4 alpha DNA-binding domain binds directly to the TATA box-binding protein (TBP) and, through this interaction, can target TBP or TFIID to promoters containing HNF4 alpha-binding sites in vitro. Supporting the functional significance of this interaction, an HNF4 alpha mutation that blocks binding of TBP to HNF4 alpha interferes with HNF4 alpha transactivation activity in cells. These findings identify an unexpected role for the HNF4 alpha DNA-binding domain in mediating key regulatory interactions and provide new insights into the roles of HNF4 alpha and TFIID in RNA polymerase II transcription.

    DOI: 10.1074/jbc.M109.017954

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Direct Inhibition of RNA Polymerase II Transcription by RECQL5 査読

    Ozan Ayguen, Xiaohua Xu, Yilun Liu, Hidehisa Takahashi, Stephanie E. Kong, Ronald C. Conaway, Joan W. Conaway, Jesper Q. Svejstrup

    JOURNAL OF BIOLOGICAL CHEMISTRY   284 ( 35 )   23197 - 23203   2009年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    DNA helicases of the RECQ family are important for maintaining genome integrity, from bacteria to humans. Although progress has been made in understanding the biochemical role of some human RECQ helicases, that of RECQL5 remains elusive. We recently reported that RECQL5 interacts with RNA polymerase II (RNAPII), pointing to a role for the protein in transcription. Here, we show that RECQL5 inhibits both initiation and elongation in transcription assays reconstituted with highly purified general transcription factors and RNAPII. Such inhibition is not observed with the related, much more active RECQL1 helicase or with a version of RECQL5 that has normal helicase activity but is impaired in its ability to interact with RNAPII. Indeed, RECQL5 helicase activity is not required for inhibition. We discuss our findings in light of the fact that RECQ5(-/-) mice have elevated levels of DNA recombination and a higher incidence of cancer.

    DOI: 10.1074/jbc.M109.015750

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Large-scale proteomic analysis of tyrosine-phosphorylation induced by T-cell receptor or B-cell receptor activation reveals new signaling pathways 査読

    Masaki Matsumoto, Koji Oyamada, Hidehisa Takahashi, Takamichi Sato, Shigetsugu Hatakeyama, Keiichi I. Nakayama

    PROTEOMICS   9 ( 13 )   3549 - 3563   2009年7月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:WILEY-V C H VERLAG GMBH  

    Activation of the T-cell receptor (TCR) and that of the B-cell receptor (BCR) elicits tyrosine-phosphorylation of proteins that belongs to similar functional categories, but result in distinct cellular responses. Large-scale analyses providing an overview of the signaling pathways downstream of TCR or BCR have not been described, so it has been unclear what components of these pathways are shared and which are specific. We have now performed a systematic analysis and provide a comprehensive list of tyrosine-phosphorylated proteins (PY proteome) with quantitative data on their abundance in T cell, B cell, and nonlymphoid cell lines. Our results led to the identification of novel tyrosine-phosphorylated proteins and signaling pathways not previously implicated in immunoreceptor signal transduction, such as clathrin, zonula occludens 2, eukaryotic translation initiation factor 3, and RhoH, suggesting that TCR or BCR signaling may be linked to downstream processes such as endocytosis, cell adhesion, and translation. Thus comparative and quantitative studies of tyrosine-phosphorylation have the potential to expand knowledge of signaling networks and to promote understanding of signal transduction at the system level.

    DOI: 10.1002/pmic.200900011

    Web of Science

    PubMed

    researchmap

  • Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex 査読

    Tingting Yao, Ling Song, Jingji Jin, Yong Cai, Hidehisa Takahashi, Selene K. Swanson, Michael P. Washburn, Laurence Florens, Ronald C. Conaway, Robert E. Cohen, Joan W. Conaway

    MOLECULAR CELL   31 ( 6 )   909 - 917   2008年9月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:CELL PRESS  

    Deubiquitinating enzymes (DUBs) are proteases that can antagonize ubiquitin-mediated signaling by disassembling ubiquitin-protein conjugates. How DUBs are regulated in vivo and how their substrate specificities are achieved are largely unknown. The conserved DUB Uch37 is found on proteasomes in organisms ranging from fission yeast to humans. Deubiquitination by Uch37 is activated by proteasomal binding, which enables Uch37 to process polyubiquitin chains. Here we show that in the nucleus Uch37 is also associated with the human Ino8O chromatin-remodeling complex (hINO80). In hINO80, Uch37 is held in an inactive state; however, it can be activated by transient interaction of the Ino80 complex with the proteasome. Thus, DUB activities can be modulated both positively and negatively via dynamic interactions with partner proteins. In addition, our findings suggest that the proteasome and the hINO80 chromatin-remodeling complex may cooperate to regulate transcription or DNA repair, processes in which both complexes have been implicated.

    DOI: 10.1016/j.molcel.2008.08.027

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation 査読

    Y Fujii, M Yada, M Nishiyama, T Kamura, H Takahashi, R Tsunematsu, E Susaki, T Nakagawa, A Matsumoto, KI Nakayama

    CANCER SCIENCE   97 ( 8 )   729 - 736   2006年8月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:BLACKWELL PUBLISHING  

    Fbxw7 (also known as Sel-10, hCdc4 or hAgo) is the F-box protein component of a Skp1-Cul1-F-box protein (SCF) ubiquitin ligase. Fbxw7 contributes to the ubiquitin-mediated degradation of cyclin E, c-Myc, Aurora-A, Notch and c-Jun, all of which appear to function as cell-cycle promoters and oncogenic proteins. Loss of Fbxw7 results in elevated expression of its substrates, which may lead to oncogenesis. However, it remains largely unclear which accumulating substrate is most related to cancer development in Fbxw7-mutant cancer cells. In the present study, we examined the abundance of cyclin E, c-Myc and Aurora-A in seven cancer cell lines, which harbor wild-type (three lines) or mutant (four lines) Fbxw7. Although these three substrates accumulated in the Fbxw7-mutant cells, the extent of increase in the expression of these proteins varied in each line. Forced expression of Fbxw7 reduced the levels of cyclin E, c-Myc and Aurora-A in the Fbxw7-mutant cells. In contrast, a decrease in the expression of cyclin E, c-Myc or Aurora-A by RNA interference significantly suppressed the rate of proliferation and anchorage-independent growth of the Fbxw7-mutant cells. These findings thus suggest that the loss of Fbxw7 results in accumulation of cyclin E, c-Myc and Aurora-A, all of which appear to be required for growth promotion of cancer cells. Fbxw7 seems to regulate the levels of multiple targets to suppress cancer development.

    DOI: 10.1111/j.1349-7006.2006.00239.x

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Role of the UBL-UBA protein KPC2 in degradation of p27 at G(1) phase of the cell cycle 査読

    T Hara, T Kamura, S Kotoshiba, H Takahashi, K Fujiwara, Onoyama, I, M Shirakawa, N Mizushima, KI Nakayama

    MOLECULAR AND CELLULAR BIOLOGY   25 ( 21 )   9292 - 9303   2005年11月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC MICROBIOLOGY  

    KPC2 (Kip1 ubiquitylation-promoting complex 2) together with KPC1 forms the ubiquitin ligase KPC, which regulates degradation of the cyclin-dependent kinase inhibitor p27 at the G, phase of the cell cycle. KPC2 contains a ubiquitin-like (UBL) domain, two ubiquitin-associated (UBA) domains, and a heat shock chaperonin-binding (STI1) domain. We now show that KPC2 interacts with KPC1 through its UBL domain, with the 26S proteasome through its UBL and NH2-terminal UBA domains, and with polyubiquitylated proteins through its UBA domains. The association of KPC2 with KPC1 was found to stabilize KPC1 in a manner dependent on the STI1 domain of KPC2. KPC2 mutants that lacked either the NH2-terminal or the COOH-terminal UBA domain supported the polyubiquitylation of p27 in vitro, whereas a KPC2 derivative lacking the STI1 domain was greatly impaired in this regard. Depletion of KPC2 by RNA interference resulted in inhibition of p27 degradation at the G, phase, and introduction of KPC2 derivatives into the KPC2-depleted cells revealed that the NH2-terminal UBA domain of KPC2 is essential for p27 degradation. These observations suggest that KPC2 cooperatively regulates p27 degradation with KPC1 and that the STI1 domain as well as the UBL and UBA domains of KPC2 are indispensable for its function.

    DOI: 10.1128/MCB.25.21.9292-9303.2005

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

  • Noncovalent SUMO-1 binding act ivity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein 査読

    H Takahashi, S Hatakeyama, H Saitoh, KI Nakayama

    JOURNAL OF BIOLOGICAL CHEMISTRY   280 ( 7 )   5611 - 5621   2005年2月

     詳細を見る

    記述言語:英語   掲載種別:研究論文(学術雑誌)   出版者・発行元:AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

    SUMO-1 is a member of a family of ubiquitin-like molecules that are post-translationally conjugated to various cellular proteins in a process that is mechanistically similar to ubiquitylation. To identify molecules that bind noncovalently to SUMO-1, we performed yeast two-hybrid screening with a SUMO-1 mutant that cannot be conjugated to target proteins as the bait. This screening resulted in the isolation of cDNAs encoding the b isoform of thymine DNA glycosylase (TDGb). A deletion mutant of TDGb (TDGb(Delta11)) that lacks a region shown to be required for noncovalent binding of SUMO-1 was also found not to be susceptible to SUMO-1 conjugation at an adjacent lysine residue, suggesting that such binding is required for covalent modification. In contrast, another mutant of TDGb (TDGb(KR)) in which the lysine residue targeted for SUMO-1 conjugation is replaced with arginine retained the ability to bind SUMO-1 noncovalently. TDGb was shown to interact with the promyelocytic leukemia protein (PML) in vitro as well as to colocalize with this protein to nuclear bodies in transfected cells. TDGb(KR) also colocalized with PML, whereas TDGb(Delta11) did not, indicating that the noncovalent SUMO-1 binding activity of TDGb is required for colocalization with PML. Furthermore, SUMO-1 modification of TDGb and PML enhanced the interaction between the two proteins. These results suggest that SUMO-1 functions to tether proteins to PML-containing nuclear bodies through post-translational modification and noncovalent protein-protein interaction.

    DOI: 10.1074/jbc.M408130200

    Web of Science

    PubMed

    J-GLOBAL

    researchmap

▼全件表示

MISC

  • Cajal bodyにおけるLEC構成因子ZC3H8によるsnRNA遺伝子の発現制御機構の解明

    野口慶介, 鬼澤理紗, 阿部竜太, 池陽子, 仙石徹, 緒方一博, 井野洋子, 木村弥生, 鈴木秀文, 高橋秀尚

    日本薬学会年会要旨集(Web)   144th   2024年

     詳細を見る

  • 転写伸長およびRNAプロセッシングにおけるCDK11の機能解析

    堀内恵子, 秋山知子, 木村弥生, 高橋秀尚

    日本分子生物学会年会プログラム・要旨集(Web)   46th   2023年

     詳細を見る

  • Cajal bodyにおけるSUMO修飾の役割の解明

    小笠原智泉, 堀内恵子, 秋山知子, 木村弥生, 高橋秀尚

    日本分子生物学会年会プログラム・要旨集(Web)   46th   2023年

     詳細を見る

  • メディエーター複合体の液滴による転写ユニティー制御機構の解明

    鈴木秀文, 阿部竜太, 池陽子, 古郡華月, 小川真太郎, 豊田敦, 鈴木穣, 井野洋子, 木村弥生, 秋山智彦, 石川博子, 廣瀬智威, 山本達郎, 斉藤典子, 山口雄輝, 高橋秀尚

    日本生化学会大会(Web)   96th   2023年

     詳細を見る

  • 抗体を用いたin situビオチン標識法による核内構造体構成因子のマルチオミクス解析

    野口慶介, 鈴木秀文, 阿部竜太, 堀内恵子, 秋山智彦, 池陽子, 井野洋子, 木村弥生, 梁明秀, 梁明秀, 山口雄輝, 高橋秀尚

    日本電気泳動学会シンポジウム講演要旨集   73rd (CD-ROM)   2023年

     詳細を見る

  • 新規ビオチン標識法を用いたマルチオミクス解析によるCajal body構成因子の網羅的解析とCajal body形成メカニズムの解明

    野口慶介, 鈴木秀文, 阿部竜太, 池陽子, 井野洋子, 木村弥生, 梁明秀, 土井宏, 田中章景, 山口雄輝, 高橋秀尚

    日本分子生物学会年会プログラム・要旨集(Web)   45th   2022年

     詳細を見る

  • 新規ビオチン標識法を用いたマルチオミックス解析によるCajal body形成メカニズムの解明

    野口慶介, 鈴木秀文, 阿部竜太, 池陽子, 井野洋子, 木村弥生, 梁明秀, 土井宏, 田中章景, 山口雄輝, 高橋秀尚

    日本分子生物学会年会プログラム・要旨集(Web)   44th   2021年

     詳細を見る

  • 大脳発生過程においてPAR3はヘッジホッグ・シグナリングの制御を介して神経前駆細胞の増殖を制限する 国際誌

    廣瀬智威, 廣瀬智威, 杉谷善信, 杉谷善信, 栗原秀剛, 栗原秀剛, 風間宏美, 日下智保, 野田哲生, 野田哲生, 高橋秀尚, 大野茂男

    日本分子生物学会年会プログラム・要旨集(Web)   44th   2021年

     詳細を見る

  • 不死化・クローン化ヒト近位尿細管細胞の作成とSIRT1発現調節におけるATRAPの関与についての検討

    山地 孝拡, 山下 暁朗, 涌井 広道, 安部 えりこ, 田中 昌平, 浦手 進吾, 鈴木 徹, 藤川 由美子, 高橋 秀尚, 田村 功一

    日本内分泌学会雑誌   95 ( 4 )   1610 - 1610   2020年2月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本内分泌学会  

    researchmap

  • 新規のビオチン標識手法による核内構造体カハールボディ構成因子の網羅的解析

    野口慶介, 鈴木秀文, 阿部竜太, 池陽子, 井野洋子, 木村弥生, 梁明秀, 山口雄輝, 高橋秀尚

    日本分子生物学会年会プログラム・要旨集(Web)   43rd   2020年

     詳細を見る

  • 免疫介在性小脳失調症例で同定した抗Sez6l2抗体はSez6l2とGluR1の結合を阻害することにより病原性を呈する

    矢口 裕章, 高橋 秀尚, 矢部 一郎, 渡辺 雅彦, 畠山 鎮次

    神経免疫学   22 ( 1 )   130 - 130   2017年10月

     詳細を見る

    記述言語:日本語   出版者・発行元:日本神経免疫学会  

    researchmap

  • メディエーター複合体による転写終結制御機構

    高橋秀尚, 柴田美音, 瀧川一学, 渡部昌, 築山忠維, 山本淳一, 山口雄輝, 藤井聡, 飯田緑, RANJAN Amol, SATO Shigeo, TOMOMORI‐SATO Chieri, CONAWAY Joan, CONAWAY Ronald, 畠山鎮次

    日本生化学会大会(Web)   90th   ROMBUNNO.4P2T15‐06(3P‐0635) (WEB ONLY) - 0635)]   2017年

     詳細を見る

    記述言語:日本語   出版者・発行元:生命科学系学会合同年次大会運営事務局  

    J-GLOBAL

    researchmap

  • メディエーター複合体による転写制御機構

    高橋秀尚, 畠山鎮次

    日本生化学会大会(Web)   89th   ROMBUNNO.2T15‐01(2P‐273) (WEB ONLY) - 01(2P   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • ユビキチンリガーゼTRIM23は非定型ポリユビキチン化によるPPARγの安定化を介して脂肪細胞分化を制御する

    渡部昌, 高橋秀尚, 畠山鎮次

    日本生化学会大会(Web)   89th   ROMBUNNO.3T11‐02(3P‐108) (WEB ONLY) - 02(3P   2016年9月

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • The Novel Heart-specific Ring-finger Protein 207 Regulates Energy Metabolism in Cardiomyocytes

    Wataru Mizushima, Hidehisa Takahashi, Masashi Watanabe, Shintarou Kinugawa, Shouji Matsushima, Shingo Takada, Takashi Yokota, Takaaki Furuhata, Junichi Matsumoto, M. Tsuda, T. Katayama, T. Nakajima, S. Hatakeyama, H. Tsutsui

    CIRCULATION RESEARCH   119   2016年7月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • ユビキチンE3リガーゼTRIM23は非定型ポリユビキチン化によるPPARγの安定化を介して脂肪細胞分化を制御する

    渡部昌, 高橋秀尚, 畠山鎮次

    日本細胞生物学会大会(Web)   68th   ROMBUNNO.P1‐14 (WEB ONLY) - 70   2016年5月

     詳細を見る

    記述言語:日本語   出版者・発行元:(一社)日本細胞生物学会  

    J-GLOBAL

    researchmap

  • ユビキチンリガーゼTRIM23はPPARγの安定化を介して脂肪細胞分化を制御する

    渡部昌, 高橋秀尚, 畠山鎮次

    日本内分泌学会雑誌   92 ( 1 )   201   2016年4月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • メディエーター複合体のサブユニットMed26による転写終結制御機構

    高橋秀尚, 畠山鎮次

    日本分子生物学会年会プログラム・要旨集(Web)   39th   ROMBUNNO.3AS10‐6(3P‐0189) (WEB ONLY)   2016年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Med26はLittle elongation complexをリクルートすることでsmall nuclear RNA遺伝子の発現を制御する

    高橋秀尚, 畠山鎮次

    日本RNA学会年会要旨集   17th   78   2015年7月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • 抗神経抗体抗原であるSez6l2はAMPA受容体とADDの複合体を形成しシグナル伝達を促進する

    矢口裕章, 矢口裕章, 矢口裕章, 高橋秀尚, 矢部一郎, 渡辺雅彦, 畠山鎮次, 佐々木秀直

    Neuroimmunology   20 ( 1 )   79   2015年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • メディエーター複合体のサブユニットMED26はLittle elongation complexをリクルートすることでsnRNA遺伝子の転写を制御する

    高橋秀尚, 瀧川一学, 渡部昌, Delnur Anwar, 柴田美音, 佐藤チエリ, 佐藤滋生, Amol Ranjan, Chris W. Seidel, 築山忠維, 水島航, 林正康, 大川恭行, Joan, W. Conaway,Ronal, C. Conaway, 畠山鎮次

    北海道医学雑誌   90 ( 1 )   76 - 76   2015年

     詳細を見る

    記述言語:日本語  

    researchmap

  • RNA‐DNA結合タンパク質NonOは,SOX2プロモーター制御を介して乳癌幹細胞様表現型をコントロールする

    飯笹久, LIANG Shanshan, 高橋秀尚, 藏滿保宏, 廣瀬哲郎, 中澤誠多朗, 畠山鎮次, 川内秀之, 吉山裕規, 浜田淳一

    日本RNA学会年会要旨集   16th   139   2014年7月

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Med26はLittle elongation complexをリクルートすることでsmall nuclear RNA遺伝子の発現を制御する

    高橋秀尚, 瀧川一学, 渡部昌, ANWAR Delnur, 柴田美音, 佐藤チエリ, 佐藤滋生, RANJAN Amol, SEIDEL Chris, 築山忠維, 林正康, 大川恭行, CONAWAY Joan, CONAWAY Ronald, 畠山鎮次

    日本生化学会大会(Web)   87th   WEB ONLY 2T15P-16(3P-502) - 16]   2014年

     詳細を見る

    記述言語:日本語   出版者・発行元:(公社)日本生化学会  

    J-GLOBAL

    researchmap

  • メディエーター複合体による転写伸長制御

    高橋秀尚, 瀧川一学, 渡部昌, ANWAR Delnur, 柴田美音, 佐藤チエリ, 佐藤滋生, RANJAN Amol, SEIDEL Chris W, 築山忠維, 林正康, 大川恭行, CONAWAY Joan, CONAWAY Ronald C, 畠山鎮次

    日本分子生物学会年会プログラム・要旨集(Web)   37th   1W15-3(1P-0237) (WEB ONLY)   2014年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Med26はLittle elongation complexをリクルートすることでsmall nuclear RNA遺伝子の発現を制御する

    TAKAHASHI Hidehisa, 瀧川一学, ANWAR Delnur, 柴田美音, TOMOMORI‐SATO Chieri, SATO Shigeo, RANJAN Amol, SEIDEL Chris, 築山忠維, 渡部昌, 林正康, 大川恭行, CONAWAY Joan, CONAWAY Ronald, 畠山鎮次

    日本分子生物学会年会プログラム・要旨集(Web)   36th   1P-0182 (WEB ONLY)   2013年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • TRIM67は80K-Hを介してRasを抑制し, 神経突起形成を誘導する

    矢口 裕章, 奥村 文彦, 高橋 秀尚, 加納 崇裕, 亀田 浩之, 内ヶ島 基政, 田中 伸哉, 渡辺 雅彦, 佐々木 秀直, 畠山 鎮次

    北海道醫學雜誌 = Acta medica Hokkaidonensia   87 ( 4 )   175 - 175   2012年8月

     詳細を見る

    記述言語:日本語  

    CiNii Books

    researchmap

  • The Mediator of RNA Polymerase II Transcription: Links to Transcription Elongation and Leukemogenesis

    Joan W. Conaway, Hidehisa Takahashi, Tari J. Parmely, Chieri Tomomori-Sato, Shigeo Sato, Ronald C. Conaway

    FASEB JOURNAL   26   2012年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:FEDERATION AMER SOC EXP BIOL  

    Web of Science

    researchmap

  • 亜急性小脳失調症における自己抗体の検討

    矢口裕章, 高橋秀尚, 奥村文彦, 加納崇裕, 加納崇裕, 竹内朗子, 堀内一宏, 廣谷真, 矢部一郎, 畠山鎮次, 佐々木秀直

    日本神経免疫学会学術集会抄録集   24th   90   2012年

     詳細を見る

    記述言語:日本語  

    J-GLOBAL

    researchmap

  • Interaction of Hepatocyte nuclear factor 4alpha (HNF4alpha) with the TATA box binding protein (TBP) contributes to TFIID recruitment and HNF4alpha dependent transcription

    Hidehisa Takahashi, Skylar Martin-Brown, Michael P. Washburn, Laurence Florens, Joan W. Conaway, Ronald C. Conaway

    FASEB JOURNAL   23   2009年4月

     詳細を見る

    記述言語:英語   掲載種別:研究発表ペーパー・要旨(国際会議)   出版者・発行元:FEDERATION AMER SOC EXP BIOL  

    Web of Science

    researchmap

▼全件表示

受賞

  • 荻村孝特別研究賞

    2017年11月   日本白血病研究基金  

    高橋 秀尚

     詳細を見る

  • 若手奨励賞

    2017年7月   日本生化学会北海道支部例会  

    高橋 秀尚

     詳細を見る

共同研究・競争的資金等の研究課題

  • 抗Sez6l2抗体関連脳炎の病態解明

    研究課題/領域番号:23K06940  2023年4月 - 2026年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    矢口 裕章, 松島 理明, 近藤 豪, 高橋 秀尚

      詳細を見る

    配分額:4810000円 ( 直接経費:3700000円 、 間接経費:1110000円 )

    researchmap

  • 時空間的な多因子間相互作用の理解による転写ユニティー機構の解明の総括

    研究課題/領域番号:21H05158  2021年8月 - 2024年3月

    日本学術振興会  科学研究費助成事業  学術変革領域研究(B)

    二村 圭祐, 高橋 秀尚, 仙石 徹

      詳細を見る

    配分額:1560000円 ( 直接経費:1200000円 、 間接経費:360000円 )

    「時空間的な多因子間相互作用の理解による転写ユニティー機構の解明」領域を発展させるためには、領域内で共同研究を推進すること、技術交流を積極的に進めることが重要である。また外部に向けて、領域の活動を積極的に広報することも必要である。現在までに、二村と高橋は共同研究を行い、スプライシング制御因子が転写を直接制御することを見出し、その成果は現在論文投稿中である。また、二村は開発中の新規タンパク質を構造学的視点から深めるために仙石とディスカッションを行っている。また、高橋は仙石と転写ユニティーを構築する因子に関して共同研究を行っている。新たな技術を開発するために、領域内で積極的に議論を行い、現在の技術でアプローチできない課題や、その課題を解決するために開発するべき技術の方向性などに関するブレインストーミングを行っている。その中から、転写ユニティー機構をさらに詳細に解析する新技術を考案し、現在その開発に向けて準備を行っている。また、構造生物学においてAlpha fold2のような構造を予測・解析する新規手法についても積極的に取り入れ、領域内の研究の進捗を加速するために利用している。
    広報のために転写ユニティー領域のホームページを作成し、公開した。今後、研究業績など、領域の活動を広く国民に対して公開していく予定である。また、領域内での研究交流セミナーを行うことで、さらに共同研究を増やし、迅速に研究成果を論文化できるように進めていく。

    researchmap

  • 転写ユニティー機構を構築する多因子間相互作用の網羅的解明

    研究課題/領域番号:21H05159  2021年8月 - 2024年3月

    日本学術振興会  科学研究費助成事業 学術変革領域研究(B)  学術変革領域研究(B)

    高橋 秀尚

      詳細を見る

    配分額:54600000円 ( 直接経費:42000000円 、 間接経費:12600000円 )

    これまでの遺伝子発現制御の研究においては、核内で一連の転写のプロセスが連続反応によって進行し、RNAが合成されると考えられてきた。ところが、われわれの最近の研究によって、転写制御は従来考えられてきたようなモデルのみでは理解が困難であり、「転写プロセス全体が密な相互連携によって一体化(Unity: ユニティー)し、遺伝子発現を制御する機構」(転写ユニティー機構)の存在が強く示唆された。さらに、転写ユニティー機構では、転写制御因子(タンパク質、ゲノムDNA、RNAを含む)間における相互作用(多因子間相互作用と呼ぶ)によって転写プロセス全体が非常に密に連携し合っており、1つの転写プロセスが他の全ての転写プロセスに影響し得る一体化状態と考えられる。そこで本研究では、転写ユニティー機構における多因子間相互作用において重要な役割を果たすことが示唆されるメディエーター複合体に着目し、これらの因子の本機構における役割を解明し、転写ユニティー機構の分子メカニズムを明らかにする。さらに、多因子間相互作用による転写ユニティー機構を、分子から細胞、組織レベルまで解明する。

    researchmap

  • 新規マルチオミクス解析による液滴構成因子の網羅的同定とALS発症機構の解明

    研究課題/領域番号:21K19356  2021年7月 - 2023年3月

    日本学術振興会  科学研究費助成事業 挑戦的研究(萌芽)  挑戦的研究(萌芽)

    高橋 秀尚

      詳細を見る

    配分額:6500000円 ( 直接経費:5000000円 、 間接経費:1500000円 )

    筋萎縮性側索硬化症(ALS)においては、FUSやTDP-43などの変異型タンパク質が細胞質で凝集体(ストレスボディー)を形成することが神経細胞死を引き起こす要因となる。変異型FUSやTDP-43は細胞内の正常な凝集体の構成因子をストレスボディーに引き込むことによって、正常な凝集体の細胞機能を阻害すると考えられる。そこで本研究では、凝集体の構成因子の網羅的同定法を用いて、ALS関連因子の変異型が形成するストレスボディーの構成因子を網羅的に同定する。これらの解析によって、ストレスボディーの形成によって引き起こされるALSの発症メカニズムの解明を目指す。

    researchmap

  • Med26による新規のPol II液滴集積機構の細胞増殖分化における機能解明

    研究課題/領域番号:21H02405  2021年4月 - 2024年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    高橋 秀尚

      詳細を見る

    配分額:17290000円 ( 直接経費:13300000円 、 間接経費:3990000円 )

    われわれはこれまでにメディエーター複合体が2つの異なる転写複合体Super elongation complex(SEC)やLittle elongation complex(LEC)と共役して、それぞれ異なる遺伝子群の転写を制御することを明らかとしてきた。本研究では、細胞外からの刺激やストレスに応答してSECやLECがメディエーター複合体と共に、特定の遺伝子群の発現を転写開始から伸長、終結まで統合的に制御する機構について解明する。さらに、この機構が様々な細胞の増殖から分化への移行において果たす役割を解明し、メディエーター複合体の組織・個体における役割の解明も目指す。

    researchmap

  • 新規リン酸化シグナル伝達による乳腺幹細胞の調節機構と乳がん治療への応用

    研究課題/領域番号:20K08936  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(C)  基盤研究(C)

    佐々木 和教, 高橋 秀尚

      詳細を見る

    配分額:4290000円 ( 直接経費:3300000円 、 間接経費:990000円 )

    researchmap

  • Bassoon proteinopathyの病態解析研究

    研究課題/領域番号:20H03585  2020年4月 - 2023年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    矢部 一郎, 原 太一, 矢口 裕章, 池内 健, 高橋 秀尚, 大塚 稔久, 若林 孝一, 畠山 鎮次

      詳細を見る

    配分額:17810000円 ( 直接経費:13700000円 、 間接経費:4110000円 )

    われわれは先行研究において、一部のタウオパチー発症に神経終末アクティブゾーンに存在するbassoon蛋白を翻訳するbassoon(BSN)遺伝子の変化を見出した。そのタウオパチーは3リピート(3R)と4リピート(4R)のタウ蛋白質が蓄積する新しい病態であることも示した。さらに、今までPSPと臨床診断していた患者を対象に遺伝子解析を実施したところ、その約10%にBSN遺伝子変化を同定した。このメカニズムとして分子生物学的手法を用いて、BSN遺伝子変異がタウタンパク質を不溶性分画に移行させる病原性があることを解明した。その結果、われわれの論文を引用し、Bassoon proteinopathyという疾患概念が提唱され、BSNタンパク質やBSN遺伝子と多発性硬化症、ハンチントン病、若年性パーキンソン病などの重要な神経疾患との関連が近年相次いで報告されている(Montenegro-Venegas C, et al. Autophagy 2020, Huang TT, et al. Acta Neuropathol Commun 2020, Hoffmann-Conaway S et al. Elife 2020)。当教室では現在このBSN遺伝子変化のPSPを始めとする神経難病への関与についてさらに検討を進めている。具体的には今回の研究では、①モデル動物と細胞株においてBSN遺伝子変異がタウオパチーを惹起する病態機序と同変異が治療標的となり得る可能性、②過去の研究報告からBSNが病態に関与している可能性がある認知症関連疾患、パーキンソン症候群、多系統萎縮症、多発性硬化症などの多様な神経疾患におけるBSN遺伝子変異関与の可能性、③血漿や髄液検体を用いてBSNタンパク質を測定し、BSNタンパク質量が診断および重症度バイオマーカーになり得る可能性、の3課題を中心に研究を遂行している。

    researchmap

  • メディエーター複合体による液相形成とその転写制御機構の解明

    研究課題/領域番号:19K22401  2019年6月 - 2021年3月

    日本学術振興会  科学研究費助成事業 挑戦的研究(萌芽)  挑戦的研究(萌芽)

    高橋 秀尚

      詳細を見る

    配分額:6500000円 ( 直接経費:5000000円 、 間接経費:1500000円 )

    転写制御因子のメディエーター複合体が、液相形成のコアとして機能することが示され、液相による遺伝子制御機構の解明は国際的に大変注目されている。ところが、液相が実際にどのような因子によって構成され、どのようなメカニズムによって遺伝子発現を制御するのかに関して、明らかとなっていない。これまでに、私はメディエーター複合体のサブユニットMed26 が、転写伸長因子複合体Super elongation complex(SEC)をc-Myc やHsp70 などの腫瘍関連遺伝子領域に、Little elongation complex(LEC)をsmall nuclear RNA(snRNA)遺伝子領域にリクルートし、それらの遺伝子の転写を制御することを明らかにした。【Takahashi H, et. al. Cell 146(1), 2011】【Takahashi H, et. al. Nat Commun 6, 5941, 2015】。さらに、最近の解析によって、Med26はLECと共に核内ボディCajal bodies(CBs)に局在し、snRNA遺伝子に加えて、複製依存性ヒストン遺伝子などのmRNAにポリAの無い遺伝子の転写終結を制御することを明らかとした【Takahashi H, et al. Nat Commun, 11(1):1063, 2020】。本研究では、Med26を含むメディエーター複合体が形成する液相構成因子を網羅的に同定する手法を確立する。本方法では、Med26の抗体を用いて、周辺のタンパク質をin situでビオチン化する。ビオチン化されたタンパク質を質量分析計を用いて網羅的に同定する。本手法を確立し、メディエーター複合体が形成する液相の転写制御における役割を解明する。

    researchmap

  • Med26による新規転写制御機構と腫瘍性疾患との関わりについての解明

    研究課題/領域番号:18H02378  2018年4月 - 2021年3月

    日本学術振興会  科学研究費助成事業 基盤研究(B)  基盤研究(B)

    高橋 秀尚

      詳細を見る

    配分額:17030000円 ( 直接経費:13100000円 、 間接経費:3930000円 )

    タンパク質をコードするすべての遺伝子やnon-coding RNA 遺伝子はRNA ポリメラーゼII(Pol II)によって転写される。近年、非常に多くのヒトの遺伝子で、転写開始直後にPol IIがプロモーター近傍で一時停止していることが明らかになり、遺伝子発現の制御において転写開始後のプロセス(伸長、終結)が非常に重要な役割を果たしていることがわかってきた。Pol IIの一時停止が解除されPol IIが新生RNAの合成を再開するためにはP-TEFbやELL/EAFなどの転写伸長因子の働きが必要である。
    これまでに、申請者はメディエーター複合体のサブユニットMed26 が、転写伸長因子複合体Super elongation complex(SEC)をc-Myc やHsp70 などの腫瘍関連遺伝子領域に、Little elongation complex(LEC)をsmall nuclear RNA(snRNA)遺伝子領域にリクルートし、それらの遺伝子の転写開始後のプロセスを制御することを明らかにしてきた。【Takahashi H, et. al. Cell 146(1), 2011】【Takahashi H, et. al. Nat Commun 6, 5941, 2015】。さらに、最近の解析によって、Med26 はLEC と共に核内ボディCajal bodies(CBs)に局在し、snRNA遺伝子に加えて、複製依存性ヒストン遺伝子などのmRNAにポリAの無い遺伝子の転写終結を制御することを明らかとした。本研究によって、Med26とSECはポリAのあるmRNAの転写を制御する一方で、Med26とLECはポリA の無い遺伝子の転写を制御することが明らかとなった【Takahashi H, et al. Nat Commun, 11(1):1063, 2020】。

    researchmap

  • Med26による新規転写制御機構と腫瘍性疾患との関わりについての解明

    2018年4月 - 2020年3月

    文部科学省: 科学研究費補助金(基盤研究B) 

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • 新規の転写伸長制御因子Med26を標的とした腫瘍治療シーズ開発基盤の確立

    2017年4月 - 2019年3月

    文部科学省: 挑戦的研究(萌芽) 

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    researchmap

  • TRIMファミリータンパク質によるシグナル伝達制御

    研究課題/領域番号:15H04690  2015年 - 2017年

    文部科学省  科学研究費補助金(基盤研究(B))  基盤研究(B)

    畠山 鎮次

      詳細を見る

    資金種別:競争的資金

    配分額:5590000円 ( 直接経費:4300000円 、 間接経費:1290000円 )

    申請者らの研究により、細胞内シグナル伝達制御におけるTRIMファミリーユビキチンリガーゼ群の重要性が明らかとなった。特に、細胞増殖や細胞分化の過程を制御するシグナル伝達系に、TRIMファミリーユビキチンリガーゼが関与していることが示された。そこで本研究申請においては、網羅的ノックダウンスクリーニングやプロテオミクス的手法により、さまざまな細胞内シグナル系におけるユビキチン化を制御するTRIM型ユビキチンリガーゼを同定・解析した。さらには、siRNAライブラリーを用いたTRIMファミリー遺伝子の網羅的ノックダウンにより、代謝や免疫シグナルに関する候補遺伝子を同定し、その機能解析を行った。

    researchmap

  • 新規転写伸長制御因子Med26の混合型急性白血病への関与についての解析

    研究課題/領域番号:15H04701  2015年 - 2017年

    文部科学省  科学研究費補助金(基盤研究(B))  基盤研究(B)

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:6500000円 ( 直接経費:5000000円 、 間接経費:1500000円 )

    本研究ではMed26とSECが共役して、Pol IIの一時停止を解除し、がんや白血病などの腫瘍の増殖を促進する機構を解明するために解析を行った。さらに、Med26が2つの異なる転写伸長因子複合体SECとLECを使い分けることによって、どのようにして異なる遺伝子の転写発現を制御するのかに関して解明を行った。

    researchmap

  • 転写環境を再構成したDNAビーズによる転写制御因子同定法の確立

    研究課題/領域番号:26670130  2014年 - 2015年

    文部科学省  科学研究費補助金(挑戦的萌芽研究)  挑戦的萌芽研究

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3640000円 ( 直接経費:2800000円 、 間接経費:840000円 )

    転写因子によって、転写調節領域にリクルートされる転写制御因子の同定法の確立を行った。現在、質量分析計を用いて転写制御因子の同定を行っている。本研究推進によって、転写調節領域マイクロビーズを用いて、メディエーター複合体によって、新規の転写伸長因子複合体Little elongation complex (LEC)がsmall nuclear RNA遺伝子などのプロモーター領域にリクルートされることもわかった。

    researchmap

  • Wntシグナル抑制分子RNF43のがんへの関与

    研究課題/領域番号:25430102  2013年4月 - 2016年3月

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    築山 忠維, 畠山 鎮次, 高橋 秀尚

      詳細を見る

    配分額:5330000円 ( 直接経費:4100000円 、 間接経費:1230000円 )

    膜型ユビキチンリガーゼRNF43は、正常幹細胞や各種がん細胞で高発現することが報告されていた。しかしRNF43の機能とそのがん化に関与する分子メカニズムは不明であった。本研究において以下の解明を行い報告を行った[ Tsukiyama, MCB, 35:2007 (2015)]。
    1.RNF43はN末端側でFzdの発現調節を行い、Wnt/βcatenin, noncanonical Wntシグナルを抑制する。2.C末端側でDvlとの結合依存的に noncanonical Wntシグナルを抑制する。3.がんにおけるRNF43のミスセンス変異がWnt/βcateninシグナルの過剰活性化を引き起こす。

    researchmap

  • Med26によってリクルートされる新規転写伸長複合体LECの機能解明

    研究課題/領域番号:25118501  2013年 - 2014年

    文部科学省  科学研究費補助金(新学術領域研究(研究領域提案型))  新学術領域研究(研究領域提案型)

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:11700000円 ( 直接経費:9000000円 、 間接経費:2700000円 )

    近年、非常に多くのヒト遺伝子で、RNAポリメラーゼII (以下Pol II)が転写開始直後に一時停止していることが明らかになり、遺伝子発現において転写伸長のプロセスが重要な役割を果たしていることがわかってきた。Pol IIの一時停止が解除されPol IIがRNA合成を再開するためには転写伸長因子の働きが必要である。ところが、転写伸長因子が、どのようにして時期特異的に特定の遺伝子領域にリクルートされ、Pol IIの一時停止を解除するのかについては、ほとんどわかっていなかった。われわれはメディエーター複合体のサブユニットMed26が転写伸長因子を含む複合体Super elongation complex(SEC)を、c-MycやHsp70などの遺伝子領域にリクルートすることを明らかにした【Takahashi H, et al. Cell 2011】。最近、われわれはMed26に結合するもう一つの複合体Little elongation complex(LEC)を同定した。SECとLECは共に転写伸長因子ELL/EAFを共通のコンポ―ネントとして有し、Med26はEAFに直接結合することで、これらの複合体を遺伝子領域にリクルートする。解析を行ったところ、Med26はLECをsmall nuclear RNAやsmall nucleolar RNAなどのnon coding RNA遺伝子領域にリクルートすることがわかった。また、興味深いことに、基本転写因子TFIIDのサブユニットTAF7は、EAFと類似のアミノ酸配列領域を有しており、その領域でMed26と直接結合し、LECのnon-coding RNA遺伝子領域へのリクルートを阻害することがわかった。このように、Med26はスイッチ因子としてTAF7との結合をEAFに切り替えることで、LECをnon-coding RNA遺伝子領域にリクルートし、Pol IIによる転写伸長のオン・オフを制御する可能性が考えられる。

    researchmap

  • Pol2の転写伸長・終結・リサイクル過程におけるチェックポイント制御機構の解明

    研究課題/領域番号:24118002  2012年6月 - 2017年3月

    日本学術振興会  科学研究費助成事業  新学術領域研究(研究領域提案型)

    山口 雄輝, 田村 智彦, 高橋 秀尚, 川内 潤也, 西山 晃, 中林 潤, 磯部 智康, 山本 淳一, 加藤 淳子, 鈴木 秀文, 曹 青福, 柴田 紘孝, 舘野 峻平, 長谷川 冴妃子, 新垣 貴之, 瑞慶覧 安里, 黒滝 大翼, 藩 龍馬, 伏見 健太郎

      詳細を見る

    配分額:224250000円 ( 直接経費:172500000円 、 間接経費:51750000円 )

    Pol IIは転写サイクルの各段階において多数の因子(DNA、RNA、タンパク質(クロマチン因子、転写開始因子、転写伸長因子、転写終結因子、RNAプロセシング因子))と一過的に離合集散し、Pol II複合体のダイナミックなリモデリングを経て完全長のRNAが合成されると考えられるが、このダイナミズムについては依然不明な点が多い。本研究では、新規なPol II相互作用因子の同定・解析と生細胞内でのカイネティクス解析を通じて、Pol II複合体のリモデリング過程とその過程に存在するチェックポイントの制御機構の解明を目指した。

    researchmap

  • 細胞の増殖分化に関与するTRIM型ユビキチンリガーゼの網羅的解析

    研究課題/領域番号:24390065  2012年4月 - 2015年3月

    日本学術振興会  科学研究費助成事業  基盤研究(B)

    畠山 鎮次, 築山 忠維, 高橋 秀尚

      詳細を見る

    配分額:18720000円 ( 直接経費:14400000円 、 間接経費:4320000円 )

    ある種の癌の癌化制御においてTRIM ファミリーユビキチンリガーゼ群の重要性が明らかとなっている。特に細胞の増殖分化過程で重要な転写因子の制御に、TRIM ファミリーユビキチンリガーゼが関与していることが報告されている。今回、プロテオミクス的手法を使用し、転写因子のユビキチン化に関与するTRIM 型ユビキチンリガーゼを網羅的に解析した。その結果、いくつかの癌において、その癌化の機序に関することが明らかとなり、今後、これらの知見は癌の悪性度や早期診断等への臨床応用に貢献することが期待できる。

    researchmap

  • 新規転写伸長制御因子MED26の標的遺伝子解明と急性白血病への関与についての解析

    研究課題/領域番号:24689016  2012年 - 2014年

    文部科学省  科学研究費補助金(若手研究(A))  若手研究(A)

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:26780000円 ( 直接経費:20600000円 、 間接経費:6180000円 )

    近年、約30%のヒト遺伝子でRNAポリメラーゼII(Pol II)が転写開始直後に一時停止していることがわかり、遺伝子発現において転写伸長の制御が非常に重要な役割を果たしていることがわかってきた。Pol IIの一時停止が解除されPol IIが新生RNAの合成を再開するためには転写伸長因子が遺伝子上にリクルートされることが必要である。代表者はこれまでにメディエーター複合体のサブユニットMed26が転写伸長因子複合体“SEC”を遺伝子上にリクルートすることを明らかにした【Takahashi H, et al. Cell 2011】。本研究では、Med26がSECをリクルートする標的遺伝子を明らかにするため、Med26とSECのChIPシークエンス解析を行っている。さらに、Med26に結合するもう一つの転写伸長因子複合体“LEC”も同定し、Med26がLECをsmall nuclear RNA遺伝子領域へとリクルートし、それらの発現を制御することを明らかとした。また、SECのサブユニットのELL、AF4、AF9やENLの遺伝子はMLL遺伝子と混合型急性白血病で染色体転座がみられる。混合型急性白血病においては、転座の結果生じたMLL融合タンパク質がSECをHox遺伝子座に異常にリクルートし、その遺伝子の発現を異常に亢進させることから、メディエーター複合体もPol IIと共に(Med26とSECとの結合を介して)Hox遺伝子領域に異常にリクルートされている可能性が考えられた。現在、REH細胞と混合型急性白血病細胞(HB1119細胞:MLL-ENLを発現、MV4-11細胞:MLL-AF4を発現、THP-1細胞:MLL-AF9を発現)を用いてChIPシークエンス解析を行い、Med26を含むメディエーター転写複合体がPol IIと共にどのような遺伝子領域にリクルートされているのかに関して、明らかにしようとしている。

    researchmap

  • 核内環境を忠実に模倣したクロマチン再構成ビーズによる転写制御因子同定法の確立

    研究課題/領域番号:24659121  2012年 - 2013年

    文部科学省  科学研究費補助金(挑戦的萌芽研究)  挑戦的萌芽研究

    高橋 秀尚

      詳細を見る

    担当区分:研究代表者  資金種別:競争的資金

    配分額:3900000円 ( 直接経費:3000000円 、 間接経費:900000円 )

    ES細胞の多能性を規定する因子として発見された4つの因子が、全て転写因子であったことから、転写因子による遺伝子発現制御の重要性が再認識されている。本研究では転写因子による遺伝子発現制御の解明を目的に、肝細胞分化に必須の転写因子HNF4alphaによって特異的にリクルートされる転写制御因子を、クロマチン化転写調節領域を固定化したマイクロビーズを用いて、同定を試みた。

    researchmap

▼全件表示